,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,485,1,8,,26719694,5280805,Inactive,38788193.0,1903.0,,,Primary HTS Assay for S1P3 Antagonists,Screening,,
1,631,1,4,,26719694,5280805,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
2,631,1,4,,26719694,5280805,Inactive,22538455.0,8648.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
3,731,1,5,,26719694,5280805,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
4,731,1,5,,26719694,5280805,Inactive,32307126.0,8202.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
5,781,1,1,,26719694,5280805,Inactive,27807367.0,287022.0,,,uHTS for 14-3-3/Bad interaction inhibitors,Screening,,
6,782,1,2,,26719694,5280805,Inactive,83627717.0,13684.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
7,782,1,2,,26719694,5280805,Inactive,302699239.0,1981.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
8,880,2,1,,26719694,5280805,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
9,880,2,1,,26719694,5280805,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
10,880,2,1,,29216321,5280805,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
11,880,2,1,,29216321,5280805,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
12,950,1,1,,26719694,5280805,Inactive,231632.0,596.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2.",Screening,,
13,951,1,1,,26719694,5280805,Inactive,23396469.0,10017.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B.",Screening,,
14,952,1,1,,26719694,5280805,Inactive,1572493.0,599.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W.",Screening,,
15,1001,2,2,,26719694,5280805,Inactive,116734717.0,249.0,,EC50,uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay,Confirmatory,,
16,1006,1,6,,26719694,5280805,Inactive,,,,,Counter Screen for Luciferase-based Primary Inhibition Assays,Screening,,
17,1007,1,1,,26719694,5280805,Inactive,510901.0,598.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL.",Screening,,
18,1008,1,2,,26719694,5280805,Inactive,4757840.0,597.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1",Screening,,
19,1009,1,2,,26719694,5280805,Inactive,7582271.0,4170.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1",Screening,,
20,1012,1,4,,26719694,5280805,Inactive,116734717.0,249.0,,,uHTS identification of TNAP inhibitors in the absence of phosphate acceptor performed in luminescent assay,Screening,,
21,1016,1,4,,26719694,5280805,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of activators of bovine intestinal alkaline phosphatase,Screening,,
22,1018,2,5,,26719694,5280805,Inactive,8744934.0,,,IC50,Chemical Antagonists IAP-family anti-apoptotic proteins,Confirmatory,,
23,1019,1,4,,26719694,5280805,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of inhibitors of bovine intestinal alkaline phosphatase,Screening,,
24,1020,1,5,,26719694,5280805,Inactive,149631.0,,,,Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay,Screening,,
25,1021,1,1,,26719694,5280805,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Bid interaction inhibitors,Screening,,
26,1022,1,1,,26719694,5280805,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Noxa interaction inhibitors,Screening,,
27,1027,1,3,,26719694,5280805,Inactive,,,,,Counter Screen for Luciferase-based Primary Stimulation Assays,Screening,,
28,1032,1,2,,26719694,5280805,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
29,1032,1,2,,26719694,5280805,Inactive,62201602.0,,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
30,1040,1,2,,26719694,5280805,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for antagonists of NPY-Y1,Screening,,
31,1048,1,1,,26719694,5280805,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
32,1048,1,1,,26719694,5280805,Inactive,32307126.0,8202.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
33,1049,1,1,,26719694,5280805,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
34,1049,1,1,,26719694,5280805,Inactive,62201602.0,,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
35,1051,1,1,,26719694,5280805,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
36,1051,1,1,,26719694,5280805,Inactive,22538455.0,8648.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
37,1066,1,2,,26719694,5280805,Inactive,9937384.0,,,,High Throughput Screen to Identify Compounds that Inhibit Class II HMG-CoA Reductases  - Primary Screen,Screening,,
38,1085,1,1,,26719694,5280805,Inactive,139424501.0,5176170.0,,,uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors,Screening,,
39,1135,1,3,,26719694,5280805,Inactive,116734717.0,249.0,,,uHTS identification of compounds inhibiting TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
40,1136,1,3,,26719694,5280805,Inactive,116734717.0,249.0,,,uHTS identification of compounds activating TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
41,1189,1,5,,48414436,5280805,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
42,1191,1,3,,48414436,5280805,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Hamster Bioassay Results,Other,,
43,1194,1,3,,48414436,5280805,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
44,1203,1,3,,26719694,5280805,Inactive,12803275.0,3303.0,,,Primary cell-based high-throughput screening assay to identify transcriptional activators of heat shock protein 70 (Hsp70),Screening,,
45,1204,1,2,,48421832,5280805,Active,,,,,DSSTox (NCTRER) National Center for Toxicological Research Estrogen Receptor Binding Database,Screening,,
46,1205,1,4,,48414436,5280805,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
47,1208,1,3,,48414436,5280805,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
48,1209,2,2,,26719694,5280805,Active,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Confirmatory,,
49,1214,1,4,,26719694,5280805,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Screening,,
50,1216,1,5,,26719694,5280805,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay using a near- saturating concentration of mannose 6-phosphat,Screening,,
51,1217,1,4,,26719694,5280805,Active,17391426.0,1738.0,,,uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
52,1220,2,2,,26719694,5280805,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate,Confirmatory,,
53,1222,1,6,,26719694,5280805,Inactive,,,,EC50,High Throughput Screen for Inhibitors of ER Stress-induced Cell Death in a 384 well format.,Confirmatory,,
54,1229,1,3,,26719694,5280805,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Activators and Chemical Reducers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
55,1236,1,1,,26719694,5280805,Inactive,1628587.0,397393.0,,,uHTS for Calpain Inhibitors,Screening,,
56,1251,1,1,,26719694,5280805,Inactive,,,,,"Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen",Screening,,
57,1274,1,2,,26719694,5280805,Inactive,115298672.0,653361.0,,,"uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs)",Screening,,
58,1304,1,2,,26719694,5280805,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1,Screening,,
59,1321,1,2,,26719694,5280805,Inactive,47123300.0,7465.0,,,Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation,Screening,,
60,1325,1,2,,26719694,5280805,Inactive,62526033.0,9429.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen",Screening,,
61,1359,1,4,,26719694,5280805,Inactive,4505447.0,4887.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2,Screening,,
62,1362,1,2,,26719694,5280805,Inactive,,,,,Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen,Screening,,
63,1376,1,2,,49681540,5280805,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
64,1385,2,2,,49681540,5280805,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
65,1415,1,2,,26719694,5280805,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
66,1415,1,2,,26719694,5280805,Inactive,86301151.0,5999.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
67,1416,1,2,,26719694,5280805,Inactive,134304838.0,9451.0,,,Primary cell-based high-throughput screening assay to measure PERK inhibition,Screening,,
68,1422,1,1,,49681540,5280805,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
69,1423,1,2,,26719694,5280805,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
70,1423,1,2,,26719694,5280805,Inactive,74355113.0,85397.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
71,1424,1,1,,26719694,5280805,Inactive,34330186.0,368273.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1),Screening,,
72,1434,2,3,,26719694,5280805,Inactive,13124881.0,865.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
73,1434,2,3,,26719694,5280805,Inactive,19923198.0,861.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
74,1439,1,1,,26719694,5280805,Inactive,1166512.0,6000.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
75,1439,1,1,,26719694,5280805,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
76,1440,1,1,,26719694,5280805,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
77,1440,1,1,,26719694,5280805,Inconclusive,86990435.0,10287.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
78,1441,1,1,,26719694,5280805,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
79,1441,1,1,,26719694,5280805,Inactive,156416009.0,6004.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
80,1443,1,3,,26719694,5280805,Inactive,4507593.0,8743.0,,,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,Screening,,
81,1445,1,1,,26719694,5280805,Inactive,124512980.0,813945.0,,IC50,Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP),Confirmatory,,
82,1446,1,3,,26719694,5280805,Inactive,119579178.0,3717.0,,,Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F,Screening,,
83,1448,1,3,,26719694,5280805,Inactive,38174238.0,55283.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3),Screening,,
84,1454,1,1,,26719694,5280805,Inconclusive,66932916.0,5594.0,7.9433,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
85,1456,1,1,,26719694,5280805,Inactive,12003227.0,57468.0,,,Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen,Other,,
86,1460,1,3,,26719694,5280805,Inconclusive,92096784.0,4137.0,28.1838,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
87,1461,1,2,,26719694,5280805,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
88,1463,1,1,,26719694,5280805,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
89,1465,1,1,,49681540,5280805,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
90,1466,1,2,,26719694,5280805,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
91,1467,1,3,,26719694,5280805,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
92,1468,1,1,,26719694,5280805,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
93,1469,1,1,,26719694,5280805,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
94,1469,1,1,,29216321,5280805,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
95,1471,2,1,,29216321,5280805,Inconclusive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
96,1477,1,1,,26719694,5280805,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
97,1479,1,2,,26719694,5280805,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
98,1479,1,2,,29216321,5280805,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
99,1481,1,2,,26719694,5280805,Inactive,111305821.0,7415.0,,,Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition,Screening,,
100,1486,1,3,,26719694,5280805,Inactive,,,,,Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability.,Screening,,
101,1487,1,1,,29216321,5280805,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
102,1490,2,1,,26719694,5280805,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
103,1490,2,1,,29216321,5280805,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
104,1496,1,4,,26719694,5280805,Inactive,13124881.0,865.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
105,1496,1,4,,26719694,5280805,Inactive,19923198.0,861.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
106,1509,1,2,,26719694,5280805,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
107,1510,1,3,,26719694,5280805,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
108,1511,1,3,,49681540,5280805,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
109,1515,1,2,,26719694,5280805,Inactive,24119166.0,10741.0,,,Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9),Screening,,
110,1527,1,3,,26719694,5280805,Inactive,7381449.0,14678525.0,,,Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase,Screening,,
111,1529,1,1,,26719694,5280805,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
112,1529,1,1,,49681540,5280805,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
113,1530,1,1,,26719694,5280805,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
114,1530,1,1,,49681540,5280805,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
115,1531,1,1,,26719694,5280805,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
116,1531,1,1,,49681540,5280805,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
117,1532,1,1,,49681540,5280805,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
118,1533,1,1,,26719694,5280805,Inactive,15610402.0,888704.0,,,Rml C and D inhibition 384-well mixture HTS from 1536-well compound plates,Screening,,
119,1533,1,1,,26719694,5280805,Inactive,15610601.0,887352.0,,,Rml C and D inhibition 384-well mixture HTS from 1536-well compound plates,Screening,,
120,1554,1,1,,49681540,5280805,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
121,1556,1,4,,26719694,5280805,Inactive,27368096.0,,,,Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase,Screening,,
122,1565,2,2,,26719694,5280805,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
123,1566,2,3,,26719694,5280805,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
124,1578,3,2,,26719694,5280805,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
125,1580,1,1,,8149167,5280805,Inconclusive,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
126,1581,1,1,,8149167,5280805,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
127,1582,1,1,,8149167,5280805,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
128,1583,1,1,,8149167,5280805,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
129,1584,1,1,,8149167,5280805,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
130,1585,1,1,,8149167,5280805,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
131,1586,1,1,,8149167,5280805,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
132,1587,1,1,,8149167,5280805,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
133,1588,1,1,,8149167,5280805,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
134,1589,1,1,,8149167,5280805,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
135,1590,1,1,,8149167,5280805,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
136,1593,1,1,,8149167,5280805,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
137,1594,1,1,,8149167,5280805,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
138,1595,1,1,,8149167,5280805,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
139,1596,1,1,,8149167,5280805,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
140,1597,1,1,,8149167,5280805,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
141,1598,1,1,,8149167,5280805,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
142,1599,1,1,,8149167,5280805,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
143,1600,1,1,,8149167,5280805,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
144,1601,1,1,,8149167,5280805,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
145,1602,1,1,,8149167,5280805,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
146,1603,1,1,,8149167,5280805,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
147,1604,1,1,,8149167,5280805,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
148,1605,1,1,,8149167,5280805,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
149,1606,1,1,,8149167,5280805,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
150,1607,1,1,,8149167,5280805,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
151,1608,1,1,,8149167,5280805,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
152,1609,1,1,,8149167,5280805,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
153,1610,1,1,,8149167,5280805,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
154,1612,1,1,,8149167,5280805,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
155,1613,1,1,,8149167,5280805,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
156,1614,1,1,,8149167,5280805,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
157,1616,1,1,,8149167,5280805,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
158,1619,1,2,,26719694,5280805,Inactive,124809582.0,812021.0,,IC50,Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP),Confirmatory,,
159,1621,1,2,,49681540,5280805,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
160,1625,2,2,,26719694,5280805,Inactive,,,,EC50,HCS for Compounds that Up-Regulate Insulin Promoter Activity in MIN6 Cells,Confirmatory,,
161,1626,1,2,,26719694,5280805,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
162,1626,1,2,,49681540,5280805,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
163,1628,2,2,,26719694,5280805,Inactive,,,,IC50,HCS for Compounds that Down-Regulate Insulin Promoter Activity in MIN6 Cells,Confirmatory,,
164,1631,3,1,,26719694,5280805,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
165,1634,3,1,,26719694,5280805,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
166,1654,2,2,,26719694,5280805,Inactive,4758208.0,1845.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
167,1656,2,2,,26719694,5280805,Inactive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
168,1662,1,2,,49681540,5280805,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
169,1663,1,2,,49681540,5280805,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
170,1665,2,2,,26719694,5280805,Inactive,4503131.0,1499.0,,IC50_Mean,High Throughput Imaging Assay for Beta-Catenin,Confirmatory,,
171,1672,1,3,,49681540,5280805,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
172,1688,1,1,,29216321,5280805,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
173,1700,1,2,,26719694,5280805,Inactive,124263658.0,688.0,,,Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
174,1706,1,2,,26719694,5280805,Inactive,73745819.0,,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro),Screening,,
175,1721,1,2,,26719694,5280805,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
176,1722,1,2,,26719694,5280805,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
177,1766,1,1,,26719694,5280805,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
178,1766,1,1,,26719694,5280805,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
179,1766,1,1,,29216321,5280805,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
180,1766,1,1,,29216321,5280805,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
181,1768,1,1,,26719694,5280805,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
182,1768,1,1,,26719694,5280805,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
183,1768,1,1,,29216321,5280805,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
184,1768,1,1,,29216321,5280805,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
185,1775,1,2,,26719694,5280805,Inactive,,,,,Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission,Other,,
186,1776,1,2,,26719694,5280805,Inactive,,,,,Profiling compound fluorescence on GSH Beads with 488 nm excitation and 530 nm emission,Other,,
187,1777,3,2,,26719694,5280805,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
188,1778,3,3,,26719694,5280805,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
189,1779,2,2,,26719694,5280805,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
190,1789,1,2,,26719694,5280805,Inactive,83318444.0,3320.0,,,Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90),Screening,,
191,1800,1,2,,26719694,5280805,Inactive,125541954.0,,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
192,1813,1,2,,49681540,5280805,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
193,1814,1,2,,49681540,5280805,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
194,1817,2,2,,26719694,5280805,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
195,1822,1,3,,26719694,5280805,Active,23505220.0,813594.0,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).,Screening,,
196,1825,1,1,,26719694,5280805,Inactive,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
197,1832,2,1,,49681540,5280805,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
198,1845,1,2,,26719694,5280805,Inactive,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID),Screening,,
199,1850,2,1,,49681540,5280805,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
200,1861,2,1,,26719694,5280805,Inactive,119607128.0,2831.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7).,Screening,,
201,1863,2,1,,26719694,5280805,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
202,1863,2,1,,49681540,5280805,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
203,1865,1,1,,26719694,5280805,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
204,1868,1,4,,26719694,5280805,Inactive,4503895.0,2584.0,,Potency,qHTS Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
205,1875,2,1,,49681540,5280805,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
206,1885,2,1,,49681540,5280805,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
207,1899,1,3,,49681540,5280805,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
208,1903,2,3,,26719694,5280805,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
209,1903,2,3,,49681540,5280805,Inconclusive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
210,1906,1,3,,49681540,5280805,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
211,1910,1,2,,49681540,5280805,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
212,1947,1,2,,49681540,5280805,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
213,1950,1,3,,49681540,5280805,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
214,1956,1,1,,49681540,5280805,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
215,1961,2,2,,26719694,5280805,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
216,1962,1,2,,49681540,5280805,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
217,1974,1,2,,49681540,5280805,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
218,1979,1,1,,49681540,5280805,Inactive,994798.0,,,,Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound,Screening,,
219,1984,1,3,,26719694,5280805,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
220,1986,1,2,,26719694,5280805,Inactive,45357394.0,,,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
221,1987,1,2,,49681540,5280805,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
222,2006,3,2,,26719694,5280805,Inactive,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
223,2006,3,2,,26719694,5280805,Inactive,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
224,2006,3,2,,26719694,5280805,Inactive,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
225,2012,3,2,,26719694,5280805,Active,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
226,2013,2,2,,26719694,5280805,Inactive,33695107.0,9290.0,,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
227,2014,3,2,,26719694,5280805,Active,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
228,2016,1,3,,49681540,5280805,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
229,2023,1,3,,49681540,5280805,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
230,2025,1,3,,49681540,5280805,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
231,2029,1,3,,49681540,5280805,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
232,2052,2,1,,49681540,5280805,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
233,2057,1,2,,49681540,5280805,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
234,2058,3,2,,26719694,5280805,Inactive,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
235,2066,1,4,,49681540,5280805,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
236,2071,2,2,,26719694,5280805,Inactive,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
237,2073,2,3,,26719694,5280805,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
238,2073,2,3,,26719694,5280805,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
239,2094,1,2,,49681540,5280805,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
240,2094,1,2,,49681540,5280805,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
241,2094,1,2,,49681540,5280805,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
242,2097,1,2,,49681540,5280805,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
243,2098,1,1,,49681540,5280805,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
244,2099,1,1,,49681540,5280805,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
245,2100,1,1,,26719694,5280805,Active,119393891.0,2548.0,3.1623,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
246,2101,1,1,,26719694,5280805,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
247,2107,1,1,,26719694,5280805,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
248,2112,1,1,,26719694,5280805,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
249,2129,1,2,,49681540,5280805,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
250,2130,1,3,,49681540,5280805,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
251,2147,1,1,,26719694,5280805,Active,221046486.0,,14.1254,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
252,2156,2,2,,49681540,5280805,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
253,2174,1,3,,49681540,5280805,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
254,2177,1,3,,49681540,5280805,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
255,2216,1,3,,49681540,5280805,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
256,2221,1,2,,49681540,5280805,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
257,2227,1,2,,49681540,5280805,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
258,2234,1,2,,49681540,5280805,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
259,2235,1,2,,49681540,5280805,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
260,2237,1,2,,49681540,5280805,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
261,2239,1,2,,49681540,5280805,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
262,2240,1,1,,85842433,5280805,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
263,2241,1,1,,85842433,5280805,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
264,2242,1,1,,26719694,5280805,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
265,2247,1,2,,49681540,5280805,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
266,2275,1,1,,85842433,5280805,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
267,2280,2,3,,49681540,5280805,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
268,2288,1,1,,26719694,5280805,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
269,2289,1,1,,26719694,5280805,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
270,2300,1,3,,49681540,5280805,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
271,2313,1,1,,85842433,5280805,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
272,2314,1,2,,26719694,5280805,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
273,2314,1,2,,26719694,5280805,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
274,2315,1,2,,26719694,5280805,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
275,2315,1,2,,26719694,5280805,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
276,2316,1,1,,85842433,5280805,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Activators of the Reversal of PD-1 Mediated Inhibitors of T-Cell Inhibition,Screening,,
277,2322,1,1,,85842433,5280805,Inactive,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
278,2330,1,1,,85842433,5280805,Inactive,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
279,2380,1,2,,49681540,5280805,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
280,2435,1,2,,49681540,5280805,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
281,2445,1,2,,49681540,5280805,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
282,2451,1,2,,26719694,5280805,Inconclusive,122920737.0,,22.3342,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
283,2462,1,1,,49681540,5280805,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
284,2462,1,1,,49681540,5280805,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
285,2472,1,2,,26719694,5280805,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
286,2517,2,1,,26719694,5280805,Inconclusive,6980812.0,,25.1189,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
287,2520,1,4,,49681540,5280805,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
288,2521,1,3,,49681540,5280805,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
289,2524,1,2,,49681540,5280805,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
290,2528,1,2,,26719694,5280805,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
291,2528,1,2,,29216321,5280805,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
292,2540,1,2,,49681540,5280805,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
293,2544,1,2,,49681540,5280805,Active,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
294,2546,1,1,,26719694,5280805,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
295,2546,1,1,,29216321,5280805,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
296,2549,1,1,,26719694,5280805,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
297,2550,1,3,,49681540,5280805,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
298,2551,1,1,,26719694,5280805,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
299,2551,1,1,,29216321,5280805,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
300,2553,1,2,,49681540,5280805,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
301,2557,1,3,,49681540,5280805,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
302,2563,1,1,,49681540,5280805,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
303,2599,1,2,,49681540,5280805,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
304,2606,1,2,,49681540,5280805,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
305,2629,1,1,,49681540,5280805,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
306,2642,1,2,,49681540,5280805,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
307,2648,1,2,,49681540,5280805,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
308,2650,2,1,,49681540,5280805,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
309,2661,1,1,,49681540,5280805,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
310,2662,2,1,,26719694,5280805,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
311,2662,2,1,,29216321,5280805,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
312,2675,1,1,,26719694,5280805,Inconclusive,41281591.0,4154.0,15.8489,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
313,2676,1,2,,26719694,5280805,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
314,2685,1,1,,26719694,5280805,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
315,2690,1,2,,49681540,5280805,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
316,2716,1,1,,49681540,5280805,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
317,2717,1,2,,49681540,5280805,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
318,2718,1,1,,49681540,5280805,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
319,2732,1,1,,26719694,5280805,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
320,2751,2,2,,49681540,5280805,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
321,2796,1,4,,49681540,5280805,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
322,2797,1,2,,49681540,5280805,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
323,2805,2,2,,49681540,5280805,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
324,2806,2,2,,49681540,5280805,Active,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
325,2825,1,2,,49681540,5280805,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
326,168363,3,4,,103516775,5280805,Unspecified,,,,,Superoxide dismutase activity measured as inhibition of Cytochrome C reduction by 50% in isolated rat heart muscle subjected to global ischemia,Other,11140725.0,
327,170013,3,4,,103516775,5280805,Unspecified,,,,,Effect of compound on Glutathione peroxidase measured as disappearance of NADPH in isolated rat heart muscle subjected to global ischemia,Other,11140725.0,
328,170014,3,4,,103516775,5280805,Unspecified,,,,,Effect of compound on catalase measured as disappearance of H2O2 in isolated rat heart muscle subjected to global ischemia,Other,11140725.0,
329,215971,5,5,,103516775,5280805,Inactive,,,,,Dose required for inhibitory activity against oxidation of L-DOPA by mushroom tyrosinase at higher conc. of 200 mg/ml; Inactive,Other,,
330,253005,3,4,,103516775,5280805,Unspecified,,,,,Tested for vasorelaxant activity in rat thoracic aorta rings against PE-induced contractions,Other,15225704.0,
331,287076,4,2,,103516775,5280805,Unspecified,,,,,Inhibition of TPA-induced inflammation in mouse assessed per ear by edema assay,Other,17480098.0,
332,287077,3,4,,103516775,5280805,Unspecified,,,,,Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 1000 mol ratio/32 pmol TPA relative to TPA,Other,17480098.0,
333,287078,3,4,,103516775,5280805,Unspecified,,,,,Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 500 mol ratio/32 pmol TPA relative to TPA,Other,17480098.0,
334,287079,3,4,,103516775,5280805,Unspecified,,,,,Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 100 mol ratio/32 pmol TPA relative to TPA,Other,17480098.0,
335,287080,3,4,,103516775,5280805,Unspecified,,,,,Inhibitory effect on TPA-induced Epstein-Barr Virus early antigen activation in Raji cells at 10 mol ratio/32 pmol TPA relative to TPA,Other,17480098.0,
336,287081,3,4,,103516775,5280805,Unspecified,,,,,Cell viability of Raji cells at 1000 mol ratio/32 pmol TPA relative to TPA,Other,17480098.0,
337,289333,6,2,,103516775,5280805,Active,,,3.66,IC50,Nitric oxide scavenging activity assessed as inhibition of DAF2 oxidation,Confirmatory,17624791.0,
338,293297,7,1,,103516775,5280805,Active,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 min,Other,17166721.0,
339,293298,8,1,,103516775,5280805,Active,,,,IC50,Antioxidant activity assessed as inhibition of superoxide production by xanthine/xanthine oxidase method,Confirmatory,17166721.0,
340,293299,9,1,,103516775,5280805,Active,,,,,Antioxidant activity in BALB/c mouse BM cells assessed as inhibition of ROS production,Other,17166721.0,
341,294155,3,10,,103516775,5280805,Unspecified,6686057.0,,,,Inhibition of diphenolase activity of mushroom tyrosinase at 0.055 mM,Other,17287127.0,
342,312021,3,4,,103516775,5280805,Unspecified,,,,,DPPH radical scavenging activity assessed as absorption change at 60 ppm by spectrophotometry,Other,18047293.0,
343,332645,3,4,,103516775,5280805,Inactive,,,,,Inhibition of calf thymus DNA topoisomerase 1 catalytic domain-mediated supercoiled Escherichia coli pUC8 DNA relaxation up to 100 uM after 30 mins by agarose gel electrophoresis,Other,7769390.0,
344,332646,3,9,,103516775,5280805,Inactive,13959709.0,7153.0,,,Inhibition of human DNA topoisomerase 2 catalytic domain-mediated knotted bacteriophage P4Virl dell0 DNA unknotting up to 100 uM by agarose gel electrophoresis,Other,7769390.0,
345,332704,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes at 1000 uM,Other,7775983.0,
346,332706,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of human plasma alternative complement system assessed as hemolysis of non-sensitized rabbit erythrocytes at 1000 uM,Other,7775983.0,
347,332708,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes,Other,7775983.0,
348,333567,6,3,,103516775,5280805,Active,,,12.3,IC50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,15568781.0,
349,334634,3,5,,103516775,5280805,Unspecified,,,,,Toxicity in Salmonella Typhimurium T98 at 600 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction,Other,3069957.0,
350,334635,3,5,,103516775,5280805,Unspecified,,,,,Toxicity in Salmonella Typhimurium T98 at 300 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction,Other,3069957.0,
351,334637,3,5,,103516775,5280805,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction,Other,3069957.0,
352,335838,9,5,,103516775,5280805,Active,1168407.0,24192.0,13.0,IC50,Inhibition of aldose reductase in rat lens homogenates by fluorophotometer,Confirmatory,12193020.0,
353,336478,3,7,,103516775,5280805,Unspecified,,,,,Inhibition of COX2 at 100 uM by scintillation proximity assay,Other,12444669.0,
354,338023,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of beef heart mitochondrial NADH oxidase assessed as specific activity at 0.35 mM preincubated for 15 mins relative to control,Other,2959755.0,
355,338024,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of beef heart mitochondrial succinoxidase assessed as specific activity at 0.35 mM preincubated for 15 mins relative to control,Other,2959755.0,
356,338026,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of rat liver mitochondrial ATPase assessed as specific activity at 0.42 mM relative to control,Other,2959755.0,
357,338027,4,5,,103516775,5280805,Active,,,1.886,I50,Inhibition of beef heart mitochondrial NADH oxidase assessed per mg of protein,Confirmatory,2959755.0,
358,339056,8,1,,103516775,5280805,Active,,,7.27,ID50,Inhibition of Moloney murine leukemia virus reverse transcriptase using (riboadenylic acid)n(deoxythymidylic acid)12-18 as template primer by liquid scintillation counting,Confirmatory,1378087.0,
359,339057,8,1,,103516775,5280805,Active,,,7.33,ID50,Inhibition of Moloney murine leukemia virus reverse transcriptase using (ribocytidylic acid)n(deoxyguanylic acid)12-18 as template primer by liquid scintillation counting,Confirmatory,1378087.0,
360,339127,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of ADP-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
361,339128,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of arachidonic acid-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
362,339129,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of collagen-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
363,339130,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of platelet activity factor-induced platelet aggregation in rabbit platelet-rich plasma at 100 ug/mL after 3 mins by turbidimetric method,Other,8350094.0,
364,339141,3,6,,103516775,5280805,Unspecified,,,,,Inhibition of K(+)/Ca(2+)-induced Wistar rat thoracic aorta contraction at 100 ug/mL after 15 mins,Other,8350094.0,
365,339142,3,6,,103516775,5280805,Unspecified,,,,,Inhibition of norepinephrine-induced Wistar rat thoracic aorta phasic contraction at 100 ug/mL after 15 mins,Other,8350094.0,
366,339146,3,6,,103516775,5280805,Unspecified,,,,,Inhibition of norepinephrine-induced Wistar rat thoracic aorta tonic contraction at 100 ug/mL after 15 mins,Other,8350094.0,
367,356577,6,3,,103516775,5280805,Active,,,12.34,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Confirmatory,14575443.0,
368,356737,3,3,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity by TEAC assay,Other,11473417.0,
369,357253,6,2,,103516775,5280805,Unspecified,,,,,Inhibition of Saccharomyces cerevisiae fatty acid synthase,Other,12502337.0,
370,357254,6,2,,103516775,5280805,Unspecified,,,,,Antifungal activity against Candida albicans ATCC 90028,Other,12502337.0,
371,357255,6,2,,103516775,5280805,Unspecified,,,,,Antifungal activity against Cryptococcus neoformans ATCC 90113,Other,12502337.0,
372,360611,6,2,,103516775,5280805,Unspecified,,,,,Antiprotozoal activity against Entamoeba histolytica HM-1:IMSS trophozoites after 48 hrs by MTT/PMS assay,Other,11374974.0,
373,360612,6,2,,103516775,5280805,Unspecified,,,,,Antiprotozoal activity against Giardia lamblia IMSS:0989:1 after 48 hrs by MTT/PMS assay,Other,11374974.0,
374,365674,10,5,,103516775,5280805,Unspecified,215273868.0,5550.0,200.0,IC50,Inhibition of human brain prolyl oligopeptidase expressed in Escherichia coli,Confirmatory,18650094.0,
375,365675,6,4,,103516775,5280805,Unspecified,,,145.0,IC50,Inhibition of DPP4,Confirmatory,18650094.0,
376,366284,6,2,,103516775,5280805,Unspecified,,,87.7,IC50,Inhibition of Influenza A Jinan/15/90 H3N2 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,Confirmatory,18640042.0,
377,366285,6,2,,103516775,5280805,Unspecified,,,52.2,IC50,Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,Confirmatory,18640042.0,
378,366286,6,2,,103516775,5280805,Unspecified,,,100.0,IC50,Inhibition of Influenza A Jiangsu/10/2003 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,Confirmatory,18640042.0,
379,378763,7,1,,103516775,5280805,Inactive,,,,,Induction of resting HMNC proliferation assessed as [3H]thymidine uptake at 10 ug/mL after 3 days by lymphoproliferation test relative to control,Other,10096846.0,
380,378764,4,3,,103516775,5280805,Inactive,,,,,Induction of phytohemagglutininin-activated HMNC proliferation assessed as [3H]thymidine uptake at 10 ug/mL after 3 days by lymphoproliferation test relative to control,Other,10096846.0,
381,379089,6,2,,103516775,5280805,Unspecified,,,164.0,IC50,Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay,Confirmatory,10096863.0,
382,379096,3,4,,103516775,5280805,Active,,,,,Stimulation of BALB/c mouse cloned 3T3/A31 cells proliferation at 0.01 to 10 ug/mL,Other,10096863.0,
383,379097,3,4,,103516775,5280805,Unspecified,,,,,Stimulation of BALB/c mouse cloned 3T3/A31 cells proliferation at 0.01 ug/mL,Other,10096863.0,
384,379312,3,3,,103516775,5280805,Unspecified,,,,,"Antioxidant scavenging activity against 2,2'-azobis-amidinopropane-induced peroxyl radicals assessed as total oxyradical scavenging capacity relative to Trolox",Other,10757712.0,
385,379313,3,3,,103516775,5280805,Unspecified,,,,,"Antioxidant scavenging activity against 2,2'-azobis-amidinopropane-induced peroxyl radicals assessed as total oxyradical scavenging capacity",Other,10757712.0,
386,379565,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 1000 molar ratio relative to TPA,Other,17190444.0,
387,379566,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 500 molar ratio relative to TPA,Other,17190444.0,
388,379567,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 100 molar ratio relative to TPA,Other,17190444.0,
389,379568,3,4,,103516775,5280805,Unspecified,,,,,Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 10 molar ratio relative to TPA,Other,17190444.0,
390,379569,4,3,,103516775,5280805,Unspecified,,,,,Inhibition of TPA-induced EBV-early antigen activation in human Raji cells relative to TPA,Other,17190444.0,
391,379570,3,4,,103516775,5280805,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio,Other,17190444.0,
392,379571,3,4,,103516775,5280805,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 500 molar ratio,Other,17190444.0,
393,379572,3,4,,103516775,5280805,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 100 molar ratio,Other,17190444.0,
394,379573,3,4,,103516775,5280805,Unspecified,,,,,Cytotoxicity against human Raji cells assessed as cell viability at 10 molar ratio,Other,17190444.0,
395,380506,6,5,,103516775,5280805,Unspecified,,,80.0,IC50,Inhibition of CYP3A4,Confirmatory,16562853.0,
396,395278,6,2,,103516775,5280805,Active,,,41.9,IC50,Antiglycation activity of compound assessed as inhibition of BSA-derived advance glycated end product formation after 7 days by spectrofluorimeter,Confirmatory,19251423.0,
397,397831,4,3,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins by UV-visible spectrophotometry,Other,12502312.0,
398,399340,9,2,,103516775,5280805,Unspecified,,,52.2,IC50,Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry,Confirmatory,9461655.0,
399,399341,6,2,,103516775,5280805,Active,,,10.6,IC50,Antioxidant activity assessed as superoxide-scavenging activity by nitrite method,Confirmatory,9461655.0,
400,400607,4,3,,103516775,5280805,Unspecified,,,,,Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression at 10 uM after 18 hrs measured as microunits of tissue factor/10'5 cells,Other,8882428.0,
401,402262,3,3,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity by spectrophotometry,Other,15165152.0,
402,402263,3,3,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of free radical scavenging activity by chemiluminescence assay,Other,15165152.0,
403,402361,3,11,,103516775,5280805,Inactive,544257.0,2099.0,,,Activity at human estrogen receptor expressed in transgenic Arabidopsis plant at 400 uM by pER8-GFP reporter assay,Other,16038533.0,
404,402473,6,2,,103516775,5280805,Unspecified,,,250.0,EC50,Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by crystal violet staining,Confirmatory,9287415.0,
405,402475,6,2,,103516775,5280805,Unspecified,,,250.0,EC50,Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by [methyl-3H]thymidine incorporation assay,Confirmatory,9287415.0,
406,402483,3,4,,103516775,5280805,Active,,,,,Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality treated with drug after 2 hrs of TNFalpha treatment,Other,9287415.0,
407,402484,3,4,,103516775,5280805,Active,,,,,Potentiation of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality treated with drug after 2 hrs of TNFalpha treatment,Other,9287415.0,
408,403918,3,9,,103516775,5280805,Unspecified,2827766.0,29290.0,,,Displacement of [3H]DPCPX from adenosine A1 receptor in rat forebrain membrane assessed as fraction of receptor bound radioligand at 100 ug/mL,Other,9214739.0,
409,404008,5,1,,103516775,5280805,Unspecified,,,,,Cytotoxicity against human KB cells,Other,469554.0,
410,406716,3,3,,103516775,5280805,Unspecified,,,,,Photostability of compound assessed as sun protection factor after 120 mins,Other,18512988.0,
411,406717,3,3,,103516775,5280805,Unspecified,,,,,Photostability of compound assessed as protection factor-UVA after 120 mins,Other,18512988.0,
412,434947,1,2,,49681540,5280805,Inactive,,,300.0,EC50_uM,Luminescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of ADP-glo Reagents,Confirmatory,,
413,434954,1,1,,49681540,5280805,Active,21361340.0,2932.0,27.96,EC50_uM,Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta  Activity,Confirmatory,,
414,434955,1,2,,49681540,5280805,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
415,434959,1,1,,85842433,5280805,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
416,434962,1,2,,49681540,5280805,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
417,434970,1,2,,49681540,5280805,Inactive,124487323.0,76768.0,,,Single concentration confirmation of uHTS hits from a small molecule activators of mouse intestinal alkaline phosphatase via a luminescent assay,Screening,,
418,434971,1,2,,49681540,5280805,Inactive,124487323.0,76768.0,,,Single concentration confirmation of uHTS hits from a small molecule inhibitors of mouse intestinal alkaline phosphatase via a luminescent assay,Screening,,
419,434973,1,3,,49681540,5280805,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
420,434989,1,1,,49681540,5280805,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
421,435003,1,3,,49681540,5280805,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
422,435005,1,1,,49681540,5280805,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
423,435022,2,2,,49681540,5280805,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
424,435030,1,2,,49681540,5280805,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
425,435030,1,2,,49681540,5280805,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
426,441659,9,5,,103516775,5280805,Unspecified,116353.0,590.0,501.2,Ki,Inhibition of human plasma BChE by Ellman's method,Confirmatory,19879672.0,
427,441660,9,5,,103516775,5280805,Unspecified,113037.0,43.0,300.0,Ki,Inhibition of human recombinant AChE by Ellman's method,Confirmatory,19879672.0,
428,441661,3,3,,103516775,5280805,Active,,,,,Stability in phosphate buffer at pH 7.4 after 90 mins by spectrophotometry,Other,19879672.0,
429,441664,3,4,,103516775,5280805,Unspecified,,,,,Cytotoxicity against human HepG2 cells upto 200 umol/L after 24 hrs by MTS assay,Other,19879672.0,
430,441665,3,4,,103516775,5280805,Unspecified,,,,,Cytotoxicity against human A549 cells upto 200 umol/L after 24 hrs by MTS assay,Other,19879672.0,
431,449728,1,2,,49681540,5280805,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
432,449739,1,2,,49681540,5280805,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
433,449762,1,2,,49681540,5280805,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
434,449763,1,3,,49681540,5280805,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
435,449768,1,1,,49681540,5280805,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
436,452625,5,2,,103516775,5280805,Unspecified,,,294.46,IC50,Antiglycation activity assessed as inhibition of BSA-derived advance glycated end product formation after 9 days by spectrophotometry,Confirmatory,19837595.0,
437,453282,5,3,,103516775,5280805,Active,,,1.17,IC50,Antioxidant activity assessed as nitric oxide scavenging activity by fluorescent triazofluorescein formation assay,Confirmatory,19781949.0,
438,455702,8,5,,103516775,5280805,Active,127825.0,,30.9,IC50,Inhibition of Clostridium perfringens neuraminidase,Confirmatory,19729316.0,
439,455703,7,1,,103516775,5280805,Active,,,,IC50,Noncompetitive inhibition of recombinant influenza A virus rvH1N1 A/Bervig_Mission/1/18 neuraminidase,Confirmatory,19729316.0,
440,456316,3,3,,103516775,5280805,Unspecified,,,,,ABTS radical scavenging activity assessed as trolox equivalent antioxidant capacity,Other,19944611.0,
441,456317,3,3,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent by TEAC assay,Other,19944611.0,
442,456318,3,3,,103516775,5280805,Unspecified,,,,,DPPH radical scavenging activity assessed as trolox equivalent antioxidant capacity,Other,19944611.0,
443,462333,3,3,,103516775,5280805,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 30 uM after 72 hrs,Other,20189399.0,
444,462334,3,3,,103516775,5280805,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 10 uM after 72 hrs,Other,20189399.0,
445,462335,3,3,,103516775,5280805,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 3 uM after 72 hrs,Other,20189399.0,
446,462336,3,3,,103516775,5280805,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 1 uM after 72 hrs,Other,20189399.0,
447,462342,3,3,,103516775,5280805,Unspecified,,,,,Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 30 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay,Other,20189399.0,
448,463079,1,2,,49681540,5280805,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
449,463082,1,1,,49681540,5280805,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
450,463104,1,2,,49681540,5280805,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
451,463111,1,1,,49681540,5280805,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
452,463141,1,2,,49681540,5280805,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
453,463165,1,1,,49681540,5280805,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
454,463190,1,2,,49681540,5280805,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
455,463195,1,2,,49681540,5280805,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
456,463210,1,2,,49681540,5280805,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
457,463212,1,1,,49681540,5280805,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
458,463254,1,1,,26719694,5280805,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
459,466871,5,1,,103516775,5280805,Unspecified,14916521.0,,,,Inhibition of electric eel AChE assessed as purple zones of inhibition after 20 mins by TLC bioautography,Other,20000694.0,
460,466872,4,8,,103516775,5280805,Inconclusive,14916521.0,,,,Inhibition of electric eel AChE at 350 mM by microplate assay,Other,20000694.0,
461,468429,5,2,,103516775,5280805,Unspecified,,,,,Solubility in pH 9 buffer,Other,19846300.0,
462,478695,6,2,,103516775,5280805,Active,,,9.637,Ki,Binding affinity to adrenergic alpha2c receptor,Confirmatory,20408551.0,
463,478696,6,2,,103516775,5280805,Active,,,9.34,Ki,Binding affinity to adrenergic alpha2A receptor,Confirmatory,20408551.0,
464,481717,10,2,,103516775,5280805,Unspecified,143955315.0,,,,Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,Other,20116898.0,
465,485270,1,1,,49681540,5280805,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
466,485272,1,1,,49681540,5280805,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
467,485273,2,1,,49681540,5280805,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
468,485275,1,3,,49681540,5280805,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
469,485281,1,1,,26719694,5280805,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
470,485290,1,1,,26719694,5280805,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
471,485290,1,1,,29216321,5280805,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
472,485294,1,1,,26719694,5280805,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
473,485297,1,1,,26719694,5280805,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
474,485298,1,1,,26719694,5280805,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
475,485313,1,2,,26719694,5280805,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
476,485314,1,1,,26719694,5280805,Active,4505931.0,5423.0,8.9125,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
477,485317,1,2,,49681540,5280805,Active,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
478,485341,1,1,,26719694,5280805,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
479,485344,1,1,,26719694,5280805,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
480,485346,1,1,,49681540,5280805,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
481,485346,1,1,,49681540,5280805,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
482,485347,1,2,,26719694,5280805,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
483,485353,2,1,,26719694,5280805,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
484,485358,1,1,,26719694,5280805,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
485,485364,1,1,,26719694,5280805,Inconclusive,15149312.0,8345881.0,25.1189,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
486,485367,1,2,,26719694,5280805,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
487,488837,1,1,,26719694,5280805,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
488,488847,1,3,,49681540,5280805,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
489,488890,1,2,,49681540,5280805,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
490,488922,1,2,,49681540,5280805,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
491,488975,1,2,,49681540,5280805,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
492,488977,1,2,,49681540,5280805,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
493,489030,2,1,,49681540,5280805,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
494,489031,2,1,,49681540,5280805,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
495,492947,1,1,,26719694,5280805,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
496,492961,1,1,,29216321,5280805,Inconclusive,72386991.0,3656265.0,11.2202,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
497,492967,1,2,,99301732,5280805,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
498,493011,1,1,,49681540,5280805,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
499,493012,1,1,,49681540,5280805,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
500,493014,1,1,,26719694,5280805,Inactive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
501,493036,1,2,,49681540,5280805,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
502,493056,1,1,,26719694,5280805,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
503,493084,1,1,,26719694,5280805,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
504,493162,1,2,,99301732,5280805,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
505,493199,1,1,,29216321,5280805,Inconclusive,41281591.0,4154.0,5.1682,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding: Initial hit validation from the primary screen,Confirmatory,,
506,493205,1,1,,29216321,5280805,Inconclusive,41281591.0,4154.0,5.7988,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding: Initial hit validation in AlphaScreen assay for MBNL1-(CUG)12 binding,Confirmatory,,
507,504327,1,1,,26719694,5280805,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
508,504327,1,1,,29216321,5280805,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
509,504332,1,1,,26719694,5280805,Inconclusive,168985070.0,,10.0,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
510,504332,1,1,,29216321,5280805,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
511,504333,1,1,,26719694,5280805,Inactive,6683500.0,29994.0,,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
512,504406,1,1,,49681540,5280805,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
513,504408,2,1,,49681540,5280805,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
514,504651,1,1,,26719694,5280805,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
515,504652,1,1,,26719694,5280805,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
516,504660,1,1,,26719694,5280805,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
517,504749,1,3,,29216321,5280805,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
518,504749,1,3,1.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
519,504749,1,3,2.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
520,504749,1,3,3.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
521,504749,1,3,4.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
522,504749,1,3,5.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
523,504749,1,3,6.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
524,504749,1,3,7.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
525,504749,1,3,8.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
526,504749,1,3,9.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
527,504749,1,3,10.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
528,504749,1,3,11.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
529,504749,1,3,12.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
530,504749,1,3,13.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
531,504749,1,3,14.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
532,504749,1,3,15.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
533,504749,1,3,16.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
534,504749,1,3,17.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
535,504749,1,3,18.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
536,504749,1,3,19.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
537,504749,1,3,20.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
538,504749,1,3,21.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
539,504749,1,3,22.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
540,504749,1,3,23.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
541,504749,1,3,24.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
542,504749,1,3,25.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
543,504749,1,3,26.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
544,504749,1,3,27.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
545,504749,1,3,28.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
546,504749,1,3,29.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
547,504749,1,3,30.0,29216321,5280805,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
548,504749,1,3,31.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
549,504749,1,3,32.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
550,504749,1,3,33.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
551,504749,1,3,34.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
552,504749,1,3,35.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
553,504749,1,3,36.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
554,504749,1,3,37.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
555,504749,1,3,38.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
556,504749,1,3,39.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
557,504749,1,3,40.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
558,504749,1,3,41.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
559,504749,1,3,42.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
560,504749,1,3,43.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
561,504749,1,3,44.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
562,504749,1,3,45.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
563,504749,1,3,46.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
564,504749,1,3,47.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
565,504749,1,3,48.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
566,504749,1,3,49.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
567,504749,1,3,50.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
568,504749,1,3,51.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
569,504749,1,3,52.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
570,504749,1,3,53.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
571,504749,1,3,54.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
572,504749,1,3,55.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
573,504749,1,3,56.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
574,504749,1,3,57.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
575,504749,1,3,58.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
576,504749,1,3,59.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
577,504749,1,3,60.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
578,504749,1,3,61.0,29216321,5280805,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
579,504810,1,2,,26719694,5280805,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
580,504812,1,2,,26719694,5280805,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
581,504832,1,1,,29216321,5280805,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
582,504834,1,1,,29216321,5280805,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
583,504842,1,1,,26719694,5280805,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
584,504847,1,1,,29216321,5280805,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
585,504865,1,1,,29216321,5280805,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
586,515157,2,6,,103516775,5280805,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium TA98 assessed as inhibition of 3-nitrofluoranthene-induced mutation by Ames test,Other,20696502.0,
587,515378,4,3,,103516775,5280805,Active,,,2.53,IC50,Antioxidant activity assessed as nitric oxide scavenging activity by spectrophotometry,Confirmatory,20709556.0,
588,517389,2,7,,103516775,5280805,Active,341940616.0,108079.0,,,Inhibition of AMPK-mediated adipocyte differentiation in mouse 3T3L1 cells,Other,20822902.0,
589,517390,2,10,,103516775,5280805,Active,13432235.0,19016.0,,,Inhibition of PPAR-gamma-mediated adipocyte differentiation in mouse 3T3L1 cells,Other,20822902.0,
590,517391,2,4,,103516775,5280805,Unspecified,,,,,Cytotoxicity against mouse 3T3L1 cells at 20 uM after 24 hrs,Other,20822902.0,
591,540275,1,1,,26719694,5280805,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
592,540277,1,1,,26719694,5280805,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
593,551196,4,2,,103516775,5280805,Inactive,,,,IC50,Inhibition of human HH/Gli1-mediated transcriptional activity in tetracycline-treated human HaCaT cells treated after 12 hrs of tetracycline addition by luciferase reporter gene assay,Confirmatory,21190854.0,
594,588342,1,1,,26719694,5280805,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
595,588511,1,2,,49681540,5280805,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
596,588579,1,1,,29216321,5280805,Active,7705344.0,51426.0,23.7781,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
597,588627,1,1,,49681540,5280805,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
598,588675,1,1,,49681540,5280805,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
599,588676,1,1,,49681540,5280805,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
600,588834,2,1,,144205498,5280805,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
601,602332,1,1,,29216321,5280805,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
602,603957,1,3,,103516775,5280805,Unspecified,,,,,"Octanol-water partition coefficient, log P of the compound",Other,17629592.0,
603,616482,2,3,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity,Other,21821414.0,
604,624030,1,2,,29216321,5280805,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
605,624031,1,2,,29216321,5280805,Inconclusive,,,0.0023,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
606,624032,1,2,,29216321,5280805,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
607,624044,1,2,,29216321,5280805,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
608,624101,1,2,,85842433,5280805,Inactive,62203298.0,3417.0,,,Development of  IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
609,624136,1,1,,85842433,5280805,Inactive,208342286.0,7157.0,,,mutant P53 Measured in Biochemical System Using Small Molecule MicroArray - 2077-01_Other_SinglePoint_HTS_Activity,Screening,,
610,624138,1,1,,85842433,5280805,Inactive,21618340.0,6774.0,,,SMM STAT-3 Measured in Biochemical System Using Small Molecule MicroArray - 2076-01_Other_SinglePoint_HTS_Activity_Set2,Screening,,
611,624139,1,1,,85842433,5280805,Inactive,34577122.0,4790.0,,,NF-KappaB Measured in Biochemical System Using Small Molecule MicroArray - 2080-01_Other_SinglePoint_HTS_Activity,Screening,,
612,624141,1,1,,85842433,5280805,Inactive,71774083.0,4609.0,,,SMM c-myc Measured in Biochemical System Using Small Molecule MicroArray - 2081-01_Other_SinglePoint_HTS_Activity,Screening,,
613,624151,1,1,,85842433,5280805,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Re-Activators of the P53 Mutant Pathway Measured in Cell-Based System Using Plate Reader - 2071-01_Activator_SinglePoint_HTS_Activity,Screening,,
614,624156,1,1,,85842433,5280805,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
615,624170,1,1,,29216321,5280805,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
616,624172,1,1,,29216321,5280805,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
617,624173,1,3,,29216321,5280805,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
618,624296,1,1,,29216321,5280805,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
619,624297,1,1,,29216321,5280805,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
620,624349,1,2,,92308256,5280805,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
621,642414,1,9,,103516775,5280805,Unspecified,544257.0,2099.0,,,Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,Other,22137340.0,
622,642415,1,9,,103516775,5280805,Unspecified,544257.0,2099.0,,,Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,Other,22137340.0,
623,643972,1,4,,103516775,5280805,Inactive,,,,,Osteogenic activity in rat primary calvarial osteoblasts assessed as induction of ALP activity at 1 pM to 1 uM after 10 days by colorimetry,Other,22212722.0,
624,651631,4,1,,144205498,5280805,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
625,651631,4,1,,144209800,5280805,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
626,651632,4,1,,144205498,5280805,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
627,651632,4,1,,144209800,5280805,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
628,651633,4,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
629,651633,4,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
630,651634,4,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
631,651634,4,1,,144209800,5280805,Inconclusive,,,69.0782,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
632,651828,1,2,,92308256,5280805,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
633,651843,1,1,,144205498,5280805,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding: Counterscreen HTRF assay,Confirmatory,,
634,651843,1,1,,144205498,5280805,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding: Counterscreen HTRF assay,Confirmatory,,
635,652048,1,2,,144205498,5280805,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
636,652051,1,1,,144205498,5280805,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
637,666853,2,3,,103516775,5280805,Unspecified,,,100.0,IC50,Cytotoxicity against human LCC-6 cells after 5 days by MTS assay,Confirmatory,22743241.0,
638,666854,2,3,,103516775,5280805,Unspecified,,,100.0,IC50,Cytotoxicity against multidrug resistant human LCC-6 cells after 5 days by MTS assay,Confirmatory,22743241.0,
639,666855,2,2,,103516775,5280805,Unspecified,,,100.0,IC50,Cytotoxicity against mouse L929 cells after 5 days by MTS assay,Confirmatory,22743241.0,
640,666856,1,2,,103516775,5280805,Unspecified,,,,,Reversal of p-glycoprotein-mediated drug resistant in human LCC-6/MDR cells assessed as potentiation of paclitaxel-induced cytotoxicity at 1 uM after 5 days by MTS assay,Other,22743241.0,
641,666857,1,8,,103516775,5280805,Unspecified,67462103.0,9429.0,,,Reversal of BCRP-mediated drug resistant in human HEK293/R2 cells assessed as potentiation of topotecan-induced cytotoxicity at 1 uM after 5 days by MTS assay,Other,22743241.0,
642,666858,1,8,,103516775,5280805,Unspecified,67462103.0,9429.0,,,Reversal of BCRP-mediated drug resistant in human MCF7-MX100 cells assessed as potentiation of topotecan-induced cytotoxicity at 1 uM after 5 days by MTS assay,Other,22743241.0,
643,666859,1,8,,103516775,5280805,Unspecified,296439301.0,4363.0,,,Reversal of MRP1-mediated drug resistant in human 2008/MRP1 cells assessed as potentiation of doxorubicin-induced cytotoxicity at 1 uM after 5 days by MTS assay,Other,22743241.0,
644,686978,1,1,,144205498,5280805,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
645,686979,1,1,,144205498,5280805,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
646,690143,1,2,,103516775,5280805,Unspecified,,,,,Inhibition of oleic acid-induced triglyceride over-accumulation in human HepG2 cells incubated for 24 hrs relative to untreated control,Other,21824690.0,
647,690144,1,2,,103516775,5280805,Unspecified,,,,,Antioxidant activity in human HepG2 cells assessed as reduction of oleic acid-induced ROS generation incubated for 24 hrs by DHCF-DA based fluorimetric assay relative to untreated control,Other,21824690.0,
648,690145,1,2,,103516775,5280805,Unspecified,,,,,Cytotoxicity against human HepG2 cells incubated for 24 hrs by MTT assay,Other,21824690.0,
649,690148,1,2,,103516775,5280805,Unspecified,,,,,Reducing activity assessed as chlorogenic acid equivalent per mmol standard at 37 degC for 30 mins by Folin-Ciocalteu reagent assay assay,Other,21824690.0,
650,690149,1,2,,103516775,5280805,Unspecified,,,,,Reducing activity by cyclic voltammetry,Other,21824690.0,
651,696433,1,7,,103516775,5280805,Unspecified,585716.0,280977.0,,,Inhibition of bovine kidney LMW-PTPase at 400 uM using pNPP substrate,Other,21988196.0,
652,697852,1,7,,103516775,5280805,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
653,697853,1,7,,103516775,5280805,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
654,720516,2,1,,144205498,5280805,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
655,720516,2,1,,144209800,5280805,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
656,720532,1,1,,144205498,5280805,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
657,720533,1,1,,144205498,5280805,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
658,720552,2,1,,144205498,5280805,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
659,720552,2,1,,144209800,5280805,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
660,720554,1,3,,92308256,5280805,Inactive,52423132.0,3087402.0,,,Inhibition of the Burkholderia mallei acyl-homoserine lactone synthase BmaI1,Other,,
661,720634,2,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
662,720634,2,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
663,720635,2,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
664,720635,2,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
665,720637,2,1,,144205498,5280805,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
666,720637,2,1,,144209800,5280805,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
667,720641,1,2,,92308256,5280805,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
668,720674,2,2,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
669,720674,2,2,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
670,720675,2,2,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
671,720675,2,2,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
672,720678,2,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
673,720678,2,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
674,720679,2,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
675,720679,2,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
676,720680,2,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
677,720680,2,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
678,720681,2,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
679,720681,2,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
680,720682,2,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
681,720682,2,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
682,720683,2,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
683,720683,2,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
684,720684,2,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
685,720684,2,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
686,720685,2,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
687,720685,2,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
688,720686,2,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
689,720686,2,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
690,720687,2,2,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
691,720687,2,2,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
692,720691,4,1,,144205498,5280805,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
693,720691,4,1,,144209800,5280805,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
694,720692,3,1,,144205498,5280805,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
695,720692,3,1,,144209800,5280805,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
696,720693,3,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
697,720693,3,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
698,720717,1,3,,92308256,5280805,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
699,720719,2,1,,144205498,5280805,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
700,720719,2,1,,144209800,5280805,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
701,720725,2,1,,144205498,5280805,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
702,720725,2,1,,144209800,5280805,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
703,721628,2,5,,103516775,5280805,Active,1351907.0,280717.0,41.9,IC50,Inhibition of glycation of bovine serum albumin assessed as advanced glycated end product measured after 7 days by spectrofluorimeter in presence of glucose anhydrous,Confirmatory,23314045.0,
704,736009,3,2,,103516775,5280805,Active,,,38.7,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by microplate reader,Confirmatory,23356964.0,
705,743012,3,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
706,743012,3,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
707,743014,3,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
708,743014,3,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
709,743015,3,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
710,743015,3,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
711,743033,3,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
712,743033,3,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
713,743035,2,1,,144205498,5280805,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
714,743035,2,1,,144209800,5280805,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
715,743036,2,1,,144205498,5280805,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
716,743036,2,1,,144209800,5280805,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
717,743040,3,1,,144205498,5280805,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
718,743040,3,1,,144209800,5280805,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
719,743041,3,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
720,743041,3,1,,144209800,5280805,Inconclusive,,,61.566,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
721,743042,3,1,,144205498,5280805,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
722,743042,3,1,,144209800,5280805,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
723,743053,2,1,,144205498,5280805,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
724,743053,2,1,,144209800,5280805,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
725,743054,2,1,,144205498,5280805,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
726,743054,2,1,,144209800,5280805,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
727,743063,2,1,,144205498,5280805,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
728,743063,2,1,,144209800,5280805,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
729,743064,3,1,,144205498,5280805,Inconclusive,,,16.7855,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
730,743064,3,1,,144209800,5280805,Inconclusive,,,43.5854,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
731,743065,3,1,,144205498,5280805,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
732,743065,3,1,,144209800,5280805,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
733,743066,3,1,,144205498,5280805,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
734,743066,3,1,,144209800,5280805,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
735,743067,2,1,,144205498,5280805,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
736,743067,2,1,,144209800,5280805,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
737,743069,2,1,,144205498,5280805,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
738,743069,2,1,,144209800,5280805,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
739,743074,2,1,,144205498,5280805,Inconclusive,,,0.379,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
740,743074,2,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
741,743075,2,1,,144205498,5280805,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
742,743075,2,1,,144209800,5280805,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
743,743077,2,1,,144205498,5280805,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
744,743077,2,1,,144209800,5280805,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
745,743078,2,1,,144205498,5280805,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
746,743078,2,1,,144209800,5280805,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
747,743079,3,1,,144205498,5280805,Active,348019627.0,2099.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
748,743079,3,1,,144209800,5280805,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
749,743080,3,1,,144205498,5280805,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
750,743080,3,1,,144209800,5280805,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
751,743081,3,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
752,743081,3,1,,144209800,5280805,Inconclusive,,,61.566,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
753,743083,3,1,,144205498,5280805,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
754,743083,3,1,,144209800,5280805,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
755,743084,3,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
756,743084,3,1,,144209800,5280805,Inconclusive,,,27.5005,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
757,743085,3,1,,144205498,5280805,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
758,743085,3,1,,144209800,5280805,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
759,743086,3,1,,144205498,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
760,743086,3,1,,144209800,5280805,Inconclusive,,,77.507,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
761,743091,2,1,,144205498,5280805,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
762,743091,2,1,,144209800,5280805,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
763,743094,3,1,,144205498,5280805,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
764,743094,3,1,,144209800,5280805,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
765,743122,2,1,,144205498,5280805,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
766,743122,2,1,,144209800,5280805,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
767,743139,2,1,,144205498,5280805,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
768,743139,2,1,,144209800,5280805,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
769,743140,2,1,,144205498,5280805,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
770,743140,2,1,,144209800,5280805,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
771,743191,3,1,,144209800,5280805,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
772,743191,3,1,,170465691,5280805,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
773,743194,3,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
774,743194,3,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
775,743199,2,1,,144209800,5280805,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
776,743199,2,1,,170465691,5280805,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
777,743202,4,1,,144209800,5280805,Inconclusive,20149576.0,4780.0,0.6157,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
778,743202,4,1,,170465691,5280805,Inconclusive,20149576.0,4780.0,4.216,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
779,743203,3,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
780,743203,3,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
781,743209,3,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
782,743209,3,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
783,743210,4,1,,144209800,5280805,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
784,743210,4,1,,170465691,5280805,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
785,743211,3,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
786,743211,3,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
787,743212,3,1,,144209800,5280805,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
788,743212,3,1,,170465691,5280805,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
789,743213,3,1,,144209800,5280805,Inconclusive,,,0.0621,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
790,743213,3,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
791,743215,3,1,,144209800,5280805,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
792,743215,3,1,,170465691,5280805,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
793,743217,3,1,,144209800,5280805,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
794,743217,3,1,,170465691,5280805,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
795,743218,3,1,,144209800,5280805,Inconclusive,,,1.2395,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
796,743218,3,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
797,743219,3,1,,144209800,5280805,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
798,743219,3,1,,170465691,5280805,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
799,743220,3,1,,144209800,5280805,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
800,743220,3,1,,170465691,5280805,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
801,743221,3,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
802,743221,3,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
803,743222,3,1,,144209800,5280805,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
804,743222,3,1,,170465691,5280805,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
805,743223,3,1,,144209800,5280805,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
806,743223,3,1,,170465691,5280805,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
807,743224,3,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
808,743224,3,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
809,743225,3,1,,144209800,5280805,Inconclusive,,,0.4934,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
810,743225,3,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
811,743226,2,1,,144209800,5280805,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
812,743226,2,1,,170465691,5280805,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
813,743227,2,1,,144209800,5280805,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
814,743227,2,1,,170465691,5280805,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
815,743228,3,1,,144209800,5280805,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
816,743228,3,1,,170465691,5280805,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
817,743239,2,1,,144209800,5280805,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
818,743239,2,1,,170465691,5280805,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
819,743240,2,1,,144209800,5280805,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
820,743240,2,1,,170465691,5280805,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
821,743241,2,1,,144209800,5280805,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
822,743241,2,1,,170465691,5280805,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
823,743242,2,1,,144209800,5280805,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
824,743242,2,1,,170465691,5280805,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
825,743244,1,1,,144205498,5280805,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
826,743268,1,1,,172080372,5280805,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-labeled substrate oligonucliotide bound to E. coli SSB,Screening,,
827,743270,1,1,,172080372,5280805,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening  assay of the NIH Clinical Collections to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
828,743271,1,1,,172080372,5280805,Inactive,,,,,Biochemical high throughput counterscreening assay of the NIH Clinical Collection for inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3): fluorescence polarization based assay to identify compounds that can displace E. coli single stranded binding protein,Screening,,
829,743272,1,1,,172080372,5280805,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: a biochemical high-throughput screening assay to identify compounds that cause fluorescent interference,Screening,,
830,743281,1,1,,46386546,5280805,Inactive,1778357.0,22341.0,,,Microplate-based screening for small molecule inhibitors of Neuropilin-2/VEGF-C interactions,Screening,,
831,743281,1,1,,46386546,5280805,Inactive,219520294.0,8828.0,,,Microplate-based screening for small molecule inhibitors of Neuropilin-2/VEGF-C interactions,Screening,,
832,750845,1,2,,103516775,5280805,Active,,,4.7,IC50,Antioxidant activity assessed as nitric oxide scavenging activity after 150 mins by Greiss method,Confirmatory,23691929.0,
833,750846,1,1,,103516775,5280805,Active,,,19.4,IC50,Antioxidant activity assessed as hydroxyl radical scavenging activity after 15 mins by spectrophotometric analysis,Confirmatory,23691929.0,
834,750847,1,1,,103516775,5280805,Unspecified,,,10106.7,IC50,Antioxidant activity after 30 mins by ABTS+ radical cation decolourization assay,Confirmatory,23691929.0,
835,750848,1,2,,103516775,5280805,Active,,,4.7,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity by spectrophotometric analysis,Confirmatory,23691929.0,
836,750849,1,1,,103516775,5280805,Active,,,18.5,IC50,Metal chelating activity of the compound after 10 mins by spectrophotometric analysis,Confirmatory,23691929.0,
837,750850,1,1,,103516775,5280805,Unspecified,,,7794.4,IC50,Antioxidant activity assessed as ferric ion reducing activity after 30 mins by spectrophotometric analysis,Confirmatory,23691929.0,
838,768928,1,5,,103516775,5280805,Inactive,135807.0,2147.0,,,Inhibition of human thrombin amidolytic activity using D-Phe-Pip-Arg-pNA as substrate at 0.1 to 1000 uM preincubated for 10 mins followed by substrate addition measured every 12 secs for 10 mins by spectrophotometric analysis,Other,24610996.0,
839,1064278,1,2,,103516775,5280805,Active,,,4.7,IC50,Antioxidant activity assessed as superoxide radical scavenging activity by NBT reduction assay,Confirmatory,24387661.0,
840,1064279,1,2,,103516775,5280805,Active,,,19.4,IC50,Antioxidant activity assessed as hydroxyl radical scavenging activity after 15 mins by spectrophotometric analysis,Confirmatory,24387661.0,
841,1064280,1,3,,103516775,5280805,Active,,,4.7,IC50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,24387661.0,
842,1064281,1,2,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as EDTA equivalent of chelating effect after 10 mins by spectrophotometric analysis,Other,24387661.0,
843,1064282,1,2,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity after 30 mins by TEAC assay,Other,24387661.0,
844,1064283,1,2,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as ferric ion reducing activity using fe3+-TPTZ by FRAP assay,Other,24387661.0,
845,1071676,1,4,,103516775,5280805,Unspecified,730357.0,11433.0,,,Inhibition of TRAP activity in RANKL-induced Balb/c mouse RAW264.7 cells at 10 uM after 1 hr by ELISA relative to control,Other,24485782.0,
846,1071677,1,4,,103516775,5280805,Unspecified,730357.0,11433.0,,,Inhibition of TRAP activity in Balb/c mouse RAW264.7 cells at 10 uM after 1 hr by ELISA relative to control,Other,24485782.0,
847,1071678,1,4,,103516775,5280805,Unspecified,730357.0,11433.0,,,Inhibition of TRAP activity in RANKL-induced Balb/c mouse RAW264.7 cells at 1 uM after 1 hr by ELISA relative to control,Other,24485782.0,
848,1071679,1,4,,103516775,5280805,Unspecified,730357.0,11433.0,,,Inhibition of TRAP activity in Balb/c mouse RAW264.7 cells at 1 uM after 1 hr by ELISA relative to control,Other,24485782.0,
849,1071680,1,1,,103516775,5280805,Unspecified,,,,,Antiosteoporotic activity in alpha-MEM-induced C57BL/6 mouse MC3T3-E1 cells assessed as increase in mineralization by measuring calcium deposition at 5 uM by Alizarin Red staining assay relative to control,Other,24485782.0,
850,1071681,1,1,,103516775,5280805,Unspecified,,,,,Antiosteoporotic activity in C57BL/6 mouse MC3T3-E1 cells assessed as increase in mineralization by measuring calcium deposition at 5 uM by Alizarin Red staining assay relative to control,Other,24485782.0,
851,1071682,1,1,,103516775,5280805,Unspecified,,,,,Antiosteoporotic activity in alpha-MEM-induced C57BL/6 mouse MC3T3-E1 cells assessed as increase in collagen synthesis at 5 uM by Sirius Red-based colorimetric assay relative to control,Other,24485782.0,
852,1071683,1,1,,103516775,5280805,Unspecified,,,,,Antiosteoporotic activity in C57BL/6 mouse MC3T3-E1 cells assessed as increase in collagen synthesis at 5 uM by Sirius Red-based colorimetric assay relative to control,Other,24485782.0,
853,1071684,1,2,,103516775,5280805,Active,,,,,Antioxidant activity assessed as reduction of Cu2+ to Cu+ at 10 uM,Other,24485782.0,
854,1071685,1,2,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of APPH-induced peroxyl radical scavenging activity measured every 2 mins by ORAC fluorescence assay,Other,24485782.0,
855,1071686,1,2,,103516775,5280805,Active,,,,,Antioxidant activity assessed as trolox equivalent of APPH-induced peroxyl radical scavenging activity at 1 uM measured every 2 mins by ORAC fluorescence assay,Other,24485782.0,
856,1071840,4,1,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as rosebengal-induced singlet oxygen radical scavenging activity by ESR spin trapping method,Other,24507926.0,
857,1071843,4,2,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as AAPH-induced alkoxyl radical scavenging activity by ESR spin trapping method,Other,24507926.0,
858,1071844,4,1,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as riboflavin/EDTA-induced superoxide anion radical scavenging activity by ESR spin trapping method,Other,24507926.0,
859,1082326,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
860,1082327,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 72 hr post dose by stereoscopic microscopy,Other,21780738.0,
861,1082328,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 72 hr post dose by stereoscopic microscopy,Other,21780738.0,
862,1082334,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
863,1082335,1,1,,103516775,5280805,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
864,1082336,1,1,,103516775,5280805,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
865,1082337,1,1,,103516775,5280805,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
866,1082338,1,1,,103516775,5280805,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
867,1082339,1,1,,103516775,5280805,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
868,1082340,1,1,,103516775,5280805,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under dark conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
869,1082341,1,1,,103516775,5280805,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
870,1082342,1,1,,103516775,5280805,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
871,1082343,1,1,,103516775,5280805,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
872,1082344,1,1,,103516775,5280805,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
873,1082345,1,1,,103516775,5280805,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 2% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
874,1082346,1,1,,103516775,5280805,Inactive,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 5% under light conditions measured 5 to 60 min post dose by stereoscopic microscopy,Other,21780738.0,
875,1082347,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
876,1082348,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
877,1082349,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under dark conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
878,1082350,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under dark conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
879,1082351,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under dark conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
880,1082352,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under dark conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
881,1082355,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
882,1082356,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 48 hr post dose by stereoscopic microscopy,Other,21780738.0,
883,1082357,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.125% under light conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
884,1082358,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.25% under light conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
885,1082359,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 0.5% under light conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
886,1082360,1,1,,103516775,5280805,Unspecified,,,,,Nematicidal activity against Heterodera zeae infective stage larvae assessed as nematode mortality at 1% under light conditions measured 24 hr post dose by stereoscopic microscopy,Other,21780738.0,
887,1083149,1,1,,103516775,5280805,Unspecified,,,,,Nematotoxic activity against freshly hatched Meloidogyne incognita J2 (root-knot nematode) isolated from tomato roots assessed as induction of nematode paralysis measured 24 hr after immersion in compound test solutions,Other,23136941.0,
888,1083753,1,2,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as hydroxyl radical scavenging activity at 200 ug/ml,Other,,
889,1083754,1,2,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as hydroxyl radical scavenging activity at 100 ug/ml,Other,,
890,1083755,1,2,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as inhibition of xanthine-xanthine oxidase generated superoxide anion radical production at 200 ug/ml after 30 min by NBT reduction assay,Other,,
891,1083756,1,2,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as inhibition of xanthine-xanthine oxidase generated superoxide anion radical production at 100 ug/ml after 30 min by NBT reduction assay,Other,,
892,1083757,1,2,,103516775,5280805,Unspecified,,,,,"Antihyperlipidemic activity in Rattus norvegicus Charles Foster (rat) trition WR-1339-induced hyperlipidimic model assessed as reduction of total triglyceride level in plasma at 200 mg/kg, po",Other,,
893,1083758,1,2,,103516775,5280805,Unspecified,,,,,"Antihyperlipidemic activity in Rattus norvegicus Charles Foster (rat) trition WR-1339-induced hyperlipidimic model assessed as reduction of total phospholipid level in plasma at 200 mg/kg, po",Other,,
894,1083759,1,2,,103516775,5280805,Unspecified,,,,,"Antihyperlipidemic activity in Rattus norvegicus Charles Foster (rat) trition WR-1339-induced hyperlipidimic model assessed as reduction of total cholesterol level in plasma at 200 mg/kg, po",Other,,
895,1085488,1,2,,103516775,5280805,Inactive,,,,,Antifungal activity against Candida albicans PC31 at 0.06 mg/ml after 48 hr,Other,,
896,1085489,1,2,,103516775,5280805,Inactive,,,,,Antifungal activity against Candida albicans PC31 at 0.15 mg/ml after 48 hr,Other,,
897,1085490,1,2,,103516775,5280805,Inactive,,,,,Antifungal activity against Candida albicans PC31 at 0.30 mg/ml after 48 hr,Other,,
898,1085491,1,2,,103516775,5280805,Inactive,,,,,Antifungal activity against Candida albicans PC31 at 0.40 mg/ml after 48 hr,Other,,
899,1085492,1,2,,103516775,5280805,Inactive,,,,,Antifungal activity against Candida albicans PC31 at 0.50 mg/ml after 48 hr,Other,,
900,1085493,1,2,,103516775,5280805,Inactive,,,,,Antifungal activity against Candida albicans PC31 at 0.60 mg/ml after 48 hr,Other,,
901,1085494,1,2,,103516775,5280805,Inactive,,,,,Antifungal activity against Candida albicans PC31 at 1.25 mg/ml after 48 hr,Other,,
902,1085495,1,2,,103516775,5280805,Inactive,,,,,Antifungal activity against Candida albicans PC31 at 1.30 mg/ml after 48 hr,Other,,
903,1085496,1,2,,103516775,5280805,Inactive,,,,,Antifungal activity against Candida albicans PC31 at 1.60 mg/ml after 48 hr,Other,,
904,1085497,1,2,,103516775,5280805,Inactive,,,,,Antifungal activity against Candida albicans PC31 at 1.90 mg/ml after 48 hr,Other,,
905,1085498,1,2,,103516775,5280805,Inactive,,,,,Antifungal activity against Candida albicans PC31 at 2.10 mg/ml after 48 hr,Other,,
906,1085499,1,2,,103516775,5280805,Active,,,,,Antifungal activity against Candida albicans PC31 at 2.50 mg/ml after 48 hr,Other,,
907,1085500,1,2,,103516775,5280805,Active,,,,,Antifungal activity against Candida albicans PC31 at 2.20 mg/ml after 48 hr,Other,,
908,1085501,2,1,,103516775,5280805,Unspecified,,,,,"1-octanol-water partition coefficient, log P of the compound",Other,,
909,1090647,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Verticillium dahliae assessed as inhibition of mycelial radial growth measured after 350 hr,Other,17394331.0,
910,1095176,1,3,,103516775,5280805,Unspecified,,,,,"Antioxidant activity in high cholesterol diet fed Mus musculus KM (mouse) assessed as MDA level in liver at 70 mg/kg, ig for 10 days (Rvb = 9.95 +/- 0.15 nmol/ml)",Other,,
911,1095177,1,2,,103516775,5280805,Unspecified,,,,,"Hypolipidemic activity in high cholesterol diet fed Mus musculus KM (mouse) assessed as high density lipoprotein cholesterol at 70 mg/kg, ig for 10 days (Rvb = 1.028 +/- 0.139 mmol/l)",Other,,
912,1095178,1,2,,103516775,5280805,Unspecified,,,,,"Hypolipidemic activity in high cholesterol diet fed Mus musculus KM (mouse) assessed as low density lipoprotein cholesterol at 70 mg/kg, ig for 10 days (Rvb = 3.386 +/- 0.958 mmol/l)",Other,,
913,1095179,1,2,,103516775,5280805,Unspecified,,,,,"Hypolipidemic activity in high cholesterol diet fed Mus musculus KM (mouse) assessed as triglyceride level at 70 mg/kg, ig for 10 days (Rvb = 1.391 +/- 0.351 mmol/l)",Other,,
914,1095180,1,2,,103516775,5280805,Unspecified,,,,,"Hypolipidemic activity in high cholesterol diet fed Mus musculus KM (mouse) assessed as total cholesterol level at 70 mg/kg, ig for 10 days (Rvb = 4.402 +/- 0.8 mmol/l)",Other,,
915,1095182,1,2,,103516775,5280805,Inactive,,,,,Antioxidant activity assessed as ferric ion reducing activity measured as trolox equivalents by FRAP assay,Other,,
916,1095183,1,2,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as ABTS radical scavenging activity,Other,,
917,1095184,1,3,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 30 min,Other,,
918,1097036,1,2,,103516775,5280805,Unspecified,,,,,Antiamoebic activity against Entamoeba histolytica,Other,,
919,1100608,1,1,,103516775,5280805,Inactive,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 5 umol/disk by paper disk method,Other,84.0,
920,1100609,1,1,,103516775,5280805,Inactive,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 0.5 umol/disk by paper disk method,Other,84.0,
921,1114437,1,2,,103516775,5280805,Inactive,,,,,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 at 100 ug/ml measured every 24 hr by BACTEC 460 radiometric assay,Other,,
922,1115338,2,3,,103516775,5280805,Active,113037.0,43.0,0.012,IC50,Inhibition of AChE (unknown origin),Confirmatory,,
923,1115536,2,1,,103516775,5280805,Active,136408.0,5644.0,17.5,Ki,Non-competitive inhibition of trypsin (unknown origin) using BApNA as substrate by Lineweaver-Burk/Dixon plot analysis,Confirmatory,,
924,1115536,2,1,,103516775,5280805,Active,136413.0,5645.0,17.5,Ki,Non-competitive inhibition of trypsin (unknown origin) using BApNA as substrate by Lineweaver-Burk/Dixon plot analysis,Confirmatory,,
925,1115536,2,1,,103516775,5280805,Active,209572698.0,5646.0,17.5,Ki,Non-competitive inhibition of trypsin (unknown origin) using BApNA as substrate by Lineweaver-Burk/Dixon plot analysis,Confirmatory,,
926,1115537,2,1,,103516775,5280805,Active,136408.0,5644.0,16.0,IC50,Inhibition of trypsin (unknown origin) using BApNA as substrate incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis,Confirmatory,,
927,1115537,2,1,,103516775,5280805,Active,136413.0,5645.0,16.0,IC50,Inhibition of trypsin (unknown origin) using BApNA as substrate incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis,Confirmatory,,
928,1115537,2,1,,103516775,5280805,Active,209572698.0,5646.0,16.0,IC50,Inhibition of trypsin (unknown origin) using BApNA as substrate incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis,Confirmatory,,
929,1115538,1,3,,103516775,5280805,Unspecified,136408.0,5644.0,,,Inhibition of trypsin (unknown origin) using BApNA as substrate at 2 mg/ml incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis,Other,,
930,1115538,1,3,,103516775,5280805,Unspecified,136413.0,5645.0,,,Inhibition of trypsin (unknown origin) using BApNA as substrate at 2 mg/ml incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis,Other,,
931,1115538,1,3,,103516775,5280805,Unspecified,209572698.0,5646.0,,,Inhibition of trypsin (unknown origin) using BApNA as substrate at 2 mg/ml incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis,Other,,
932,1116768,1,2,,103516775,5280805,Active,,,15.07,IC50,Anti-inflammatory activity in Mus musculus (mouse) RAW264.7 cells assessed as inhibition of PMA-induced macrophages respiratory burst measured up to 30 min by chemiluminescence method,Confirmatory,,
933,1117298,1,2,,170465691,5280805,Inactive,,,3.5481,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
934,1117304,1,2,,170465691,5280805,Unspecified,,,,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
935,1117305,1,2,,170465691,5280805,Unspecified,,,,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
936,1117310,1,1,,170465691,5280805,Inactive,,,3.5481300000000005,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
937,1117312,1,1,,170465691,5280805,Inactive,,,,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
938,1117314,1,1,,170465691,5280805,Inactive,,,,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
939,1117319,1,2,,26719694,5280805,Inactive,9629361.0,155459.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
940,1117319,1,2,,26719694,5280805,Inactive,13399304.0,60489.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
941,1117326,1,1,,170465691,5280805,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
942,1117329,1,1,,170465691,5280805,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
943,1117336,1,1,,170465691,5280805,Active,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
944,1117340,1,1,,170465691,5280805,Inactive,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
945,1117341,1,1,,170465691,5280805,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
946,1117342,1,1,,170465691,5280805,Active,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
947,1117343,1,1,,170465691,5280805,Active,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
948,1117346,1,1,,170465691,5280805,Inactive,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
949,1126471,1,3,,103516775,5280805,Unspecified,67476665.0,2053.0,,,Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis at 25 uM after 1 hr by fluorescence method,Other,24679441.0,
950,1126472,3,2,,103516775,5280805,Active,67476665.0,2053.0,24.3,IC50,Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis after 1 hr by fluorescence method,Confirmatory,24679441.0,
951,1126473,1,1,,103516775,5280805,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 50 uM after 18 hrs by MTT assay in presence of LPS,Other,24679441.0,
952,1126474,1,1,,103516775,5280805,Active,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 10 uM after 18 hrs by griess reaction analysis,Other,24679441.0,
953,1126475,1,1,,103516775,5280805,Inactive,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 0.4 uM after 18 hrs by griess reaction analysis,Other,24679441.0,
954,1126476,1,1,,103516775,5280805,Active,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 10 uM after 18 hrs by sandwich ELISA,Other,24679441.0,
955,1126477,1,1,,103516775,5280805,Inactive,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion at 0.4 uM after 18 hrs by sandwich ELISA,Other,24679441.0,
956,1126478,1,1,,103516775,5280805,Active,,,27.5,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 18 hrs by griess reaction analysis,Confirmatory,24679441.0,
957,1126479,1,1,,103516775,5280805,Active,,,44.5,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 18 hrs by sandwich ELISA,Confirmatory,24679441.0,
958,1159509,1,1,,144209800,5280805,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
959,1159509,1,1,,170465691,5280805,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
960,1159515,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
961,1159515,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
962,1159516,1,1,,144209800,5280805,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
963,1159516,1,1,,170465691,5280805,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
964,1159517,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
965,1159517,1,1,,170465691,5280805,Inconclusive,,,10.6822,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
966,1159518,1,1,,144209800,5280805,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
967,1159518,1,1,,170465691,5280805,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
968,1159519,1,1,,144209800,5280805,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
969,1159519,1,1,,170465691,5280805,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
970,1159520,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
971,1159520,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
972,1159521,1,1,,144209800,5280805,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
973,1159521,1,1,,170465691,5280805,Inconclusive,15928672.0,19885.0,0.0007,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
974,1159523,1,1,,144209800,5280805,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
975,1159523,1,1,,170465691,5280805,Inconclusive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
976,1159525,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
977,1159525,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
978,1159526,1,1,,144209800,5280805,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
979,1159526,1,1,,170465691,5280805,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
980,1159527,1,1,,144209800,5280805,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
981,1159527,1,1,,170465691,5280805,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
982,1159528,1,1,,144209800,5280805,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
983,1159528,1,1,,170465691,5280805,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
984,1159529,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
985,1159529,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
986,1159531,1,1,,144209800,5280805,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
987,1159531,1,1,,170465691,5280805,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
988,1159550,3,1,,252401344,5280805,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
989,1159551,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
990,1159551,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
991,1159552,1,1,,144209800,5280805,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
992,1159552,1,1,,170465691,5280805,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
993,1159553,2,1,,144209800,5280805,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
994,1159553,2,1,,170465691,5280805,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
995,1159555,1,1,,144209800,5280805,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
996,1159555,1,1,,170465691,5280805,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
997,1159607,2,1,,312309945,5280805,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
998,1159614,1,2,,170465691,5280805,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
999,1159620,1,1,,103516775,5280805,Active,,,,,Summary of drug indications.,Other,,
1000,1166579,1,2,,103516775,5280805,Active,311033403.0,56923.0,1.2,EC50,Agonist activity at human NMU2R transfected in HEK293 cells after 7 hrs by luciferase reporter gene assay,Confirmatory,25262941.0,
1001,1168621,1,1,,103516775,5280805,Active,,,41.9,IC50,Antiglycation activity using bovine serum albumin incubated at 37 degC for 7 days by spectrofluorimetry,Confirmatory,25305332.0,
1002,1168660,1,1,,103516775,5280805,Active,,,1.7,IC50,Antiviral activity against Dengue virus assessed as inhibition of viral replication,Confirmatory,25305334.0,
1003,1172639,1,1,,103516775,5280805,Unspecified,,,,,Inhibition of cell proliferation of human U251 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay,Other,25442304.0,
1004,1172640,1,1,,103516775,5280805,Unspecified,,,,,Inhibition of cell proliferation of rat C6 cells assessed as cell viability at 100 uM after 72 hrs by sulforhodamine B assay,Other,25442304.0,
1005,1175998,1,1,,103516775,5280805,Unspecified,,,,,"Octanol-water partition coefficient, log P of the compound at 5 mg/20 ml after 30 mins by spectrophotometric analysis",Other,25496805.0,
1006,1175999,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Epidermophyton floccosum (Hartz) Langeron and Milochevitch CBS 358.93 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1007,1176000,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Trichophyton rubrum (Castellani) Sabouraud IHME 4321 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1008,1176001,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Trichophyton tonsurans Malmsten CBS 483.76 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1009,1176002,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Trichophyton violaceum Malmsten CBS 459.61 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1010,1176003,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Trichophyton mentagrophytes (Robin) Blanchard CBS 160.66 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1011,1176004,1,1,,103516775,5280805,Inactive,,,,,Antifungal activity against Microsporum gypseum (Bodin) Guiart and Grigorakis IHME 3999 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1012,1176005,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Nannizzia cajetani Ajello CBS 495.70 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1013,1176006,1,1,,103516775,5280805,Inactive,,,,,Antifungal activity against Microsporum canis Bodin CBS 4727 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1014,1176007,1,1,,103516775,5280805,Inactive,,,,,Antifungal activity against Nannizzia gypsea (Bodin) Guiart et Grigoraki CBS 286.63 assessed as growth inhibition at 20 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1015,1176008,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Epidermophyton floccosum (Hartz) Langeron and Milochevitch CBS 358.93 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1016,1176009,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Trichophyton rubrum (Castellani) Sabouraud IHME 4321 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1017,1176010,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Trichophyton tonsurans Malmsten CBS 483.76 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1018,1176011,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Trichophyton violaceum Malmsten CBS 459.61 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1019,1176012,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Trichophyton mentagrophytes (Robin) Blanchard CBS 160.66 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1020,1176013,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Microsporum gypseum (Bodin) Guiart and Grigorakis IHME 3999 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1021,1176014,1,1,,103516775,5280805,Unspecified,,,,,Antifungal activity against Nannizzia cajetani Ajello CBS 495.70 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1022,1176015,1,1,,103516775,5280805,Inactive,,,,,Antifungal activity against Microsporum canis Bodin CBS 4727 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1023,1176016,1,1,,103516775,5280805,Inactive,,,,,Antifungal activity against Nannizzia gypsea (Bodin) Guiart et Grigoraki CBS 286.63 assessed as growth inhibition at 100 ug/ml measured on day 7 by sabouraud dextrose agar diffusion method relative to control,Other,25496805.0,
1024,1176017,1,2,,103516775,5280805,Active,21542418.0,4790.0,,,Inhibition of NF-kappaB (unknown origin)/32P-labeled oligonucleotide interaction at 0.1 to 10 mM after 20 mins by electrophoretic mobility shift assay,Other,25496805.0,
1025,1176017,1,2,,103516775,5280805,Active,62906901.0,5970.0,,,Inhibition of NF-kappaB (unknown origin)/32P-labeled oligonucleotide interaction at 0.1 to 10 mM after 20 mins by electrophoretic mobility shift assay,Other,25496805.0,
1026,1176017,1,2,,103516775,5280805,Active,116242678.0,4791.0,,,Inhibition of NF-kappaB (unknown origin)/32P-labeled oligonucleotide interaction at 0.1 to 10 mM after 20 mins by electrophoretic mobility shift assay,Other,25496805.0,
1027,1176018,1,1,,103516775,5280805,Unspecified,,,,,Induction of apoptosis in human K562 cells assessed as live cells at 500 uM after 3 days by Annexin-V staining-based assay (Rvb = 87.33%),Other,25496805.0,
1028,1176019,1,1,,103516775,5280805,Unspecified,,,,,Induction of apoptosis in human K562 cells assessed as live cells at 1000 uM after 3 days by Annexin-V staining-based assay (Rvb = 87.33%),Other,25496805.0,
1029,1176020,1,1,,103516775,5280805,Inactive,,,,,Induction of apoptosis in human K562 cells assessed as live cells at 5 uM after 3 days by Annexin-V staining-based assay (Rvb = 87.33%),Other,25496805.0,
1030,1176021,1,1,,103516775,5280805,Inactive,,,,,Induction of apoptosis in human K562 cells assessed as live cells at 10 uM after 3 days by Annexin-V staining-based assay (Rvb = 87.33%),Other,25496805.0,
1031,1176022,1,1,,103516775,5280805,Unspecified,,,,,Induction of apoptosis in human K562 cells assessed as early apoptotic cells at 500 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.41%),Other,25496805.0,
1032,1176023,1,1,,103516775,5280805,Unspecified,,,,,Induction of apoptosis in human K562 cells assessed as early apoptotic cells at 1000 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.41%),Other,25496805.0,
1033,1176024,1,1,,103516775,5280805,Inactive,,,,,Induction of apoptosis in human K562 cells assessed as early apoptotic cells at 5 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.41%),Other,25496805.0,
1034,1176025,1,1,,103516775,5280805,Inactive,,,,,Induction of apoptosis in human K562 cells assessed as early apoptotic cells at 10 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.41%),Other,25496805.0,
1035,1176026,1,1,,103516775,5280805,Unspecified,,,,,Induction of apoptosis in human K562 cells assessed as late apoptotic cells at 500 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.96%),Other,25496805.0,
1036,1176027,1,1,,103516775,5280805,Unspecified,,,,,Induction of apoptosis in human K562 cells assessed as late apoptotic cells at 1000 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.96%),Other,25496805.0,
1037,1176028,1,1,,103516775,5280805,Inactive,,,,,Induction of apoptosis in human K562 cells assessed as late apoptotic cells at 5 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.96%),Other,25496805.0,
1038,1176029,1,1,,103516775,5280805,Inactive,,,,,Induction of apoptosis in human K562 cells assessed as late apoptotic cells at 10 uM after 3 days by Annexin-V staining-based assay (Rvb = 5.96%),Other,25496805.0,
1039,1176030,1,1,,103516775,5280805,Unspecified,,,,,Induction of apoptosis in human K562 cells assessed as dead cells at 500 uM after 3 days by Annexin-V staining-based assay (Rvb = 1.29%),Other,25496805.0,
1040,1176031,1,1,,103516775,5280805,Unspecified,,,,,Induction of apoptosis in human K562 cells assessed as dead cells at 1000 uM after 3 days by Annexin-V staining-based assay (Rvb = 1.29%),Other,25496805.0,
1041,1176032,1,1,,103516775,5280805,Inactive,,,,,Induction of apoptosis in human K562 cells assessed as dead cells at 5 uM after 3 days by Annexin-V staining-based assay (Rvb = 1.29%),Other,25496805.0,
1042,1176033,1,1,,103516775,5280805,Inactive,,,,,Induction of apoptosis in human K562 cells assessed as dead cells at 10 uM after 3 days by Annexin-V staining-based assay (Rvb = 1.29%),Other,25496805.0,
1043,1176034,1,1,,103516775,5280805,Unspecified,,,,,Induction of apoptosis in human K562 cells assessed as apoptotic cells at 500 uM after 3 days by Annexin-V staining-based assay (Rvb = 11.37%),Other,25496805.0,
1044,1176035,1,1,,103516775,5280805,Unspecified,,,,,Induction of apoptosis in human K562 cells assessed as apoptotic cells at 1000 uM after 3 days by Annexin-V staining-based assay (Rvb = 11.37%),Other,25496805.0,
1045,1176036,1,1,,103516775,5280805,Inactive,,,,,Induction of apoptosis in human K562 cells assessed as apoptotic cells at 5 uM after 3 days by Annexin-V staining-based assay (Rvb = 11.37%),Other,25496805.0,
1046,1176037,1,1,,103516775,5280805,Inactive,,,,,Induction of apoptosis in human K562 cells assessed as apoptotic cells at 10 uM after 3 days by Annexin-V staining-based assay (Rvb = 11.37%),Other,25496805.0,
1047,1176038,1,1,,103516775,5280805,Unspecified,,,897.0,IC50,Induction of apoptosis in human K562 cells assessed as total apoptotic cells after 3 days by Annexin-V staining-based assay,Confirmatory,25496805.0,
1048,1176039,1,1,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as superoxide anion radical scavenging by photochemiluminescence method relative to trolox,Other,25496805.0,
1049,1176040,1,2,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as inhibition of AAPH-induced peroxyl radical generation by oxygen radical absorbance capacity assay relative to trolox,Other,25496805.0,
1050,1176041,1,1,,103516775,5280805,Unspecified,,,,,Antioxidant activity assessed as superoxide anion radical scavenging by photochemiluminescence method relative to trolox using formulation containing O/W,Other,25496805.0,
1051,1185947,1,1,,103516775,5280805,Unspecified,,,294.46,IC50,Antiglycation activity using BSA assessed as inhibition of AGE formation incubated at 37 degC for 9 days by fluorescence assay,Confirmatory,25069019.0,
1052,1186763,1,2,,103516775,5280805,Unspecified,143955318.0,,96.8,IC50,Inhibition of influenza A virus (A/California/07/2009(H1N1)) pdm09 neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by fluorometric assay,Confirmatory,25096296.0,
1053,1186764,1,2,,103516775,5280805,Unspecified,143955318.0,,95.9,IC50,Inhibition of influenza A virus (A/Perth/16/2009(H3N2)) neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by fluorometric assay,Confirmatory,25096296.0,
1054,1186765,1,1,,103516775,5280805,Unspecified,,,104.9,IC50,Inhibition of influenza B virus (B/Brisbane/60/2008) neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by fluorometric assay,Confirmatory,25096296.0,
1055,1186766,1,1,,103516775,5280805,Unspecified,,,328.0,CC50,Cytotoxicity against MDCK cells,Confirmatory,25096296.0,
1056,1186767,1,1,,103516775,5280805,Unspecified,,,,,"Selectivity index, ratio of CC50 for MDCK cells to IC50 for influenza A virus (A/Perth/16/2009(H3N2))",Other,25096296.0,
1057,1193988,1,1,,103516775,5280805,Unspecified,,,50.0,IC50,Inhibition of LPS-induced IL-12 p40 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA,Confirmatory,25769817.0,
1058,1193989,1,1,,103516775,5280805,Unspecified,,,50.0,IC50,Inhibition of LPS-induced IL-6 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA,Confirmatory,25769817.0,
1059,1193990,1,1,,103516775,5280805,Unspecified,,,50.0,IC50,Inhibition of LPS-induced TNF-alpha production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA,Confirmatory,25769817.0,
1060,1224834,3,1,,144209800,5280805,Inconclusive,,,48.9036,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1061,1224834,3,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1062,1224835,1,1,,144209800,5280805,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1063,1224835,1,1,,170465691,5280805,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1064,1224836,1,1,,144209800,5280805,Inconclusive,,,54.8707,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1065,1224836,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1066,1224837,1,1,,144209800,5280805,Inconclusive,,,54.8707,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1067,1224837,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1068,1224838,1,1,,144209800,5280805,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1069,1224838,1,1,,170465691,5280805,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1070,1224839,1,1,,144209800,5280805,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1071,1224839,1,1,,170465691,5280805,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1072,1224840,3,1,,144209800,5280805,Inconclusive,,,34.6211,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1073,1224840,3,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1074,1224841,3,1,,144209800,5280805,Inactive,325495545.0,2101.0,17.3517,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1075,1224841,3,1,,170465691,5280805,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1076,1224842,3,1,,144209800,5280805,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1077,1224842,3,1,,170465691,5280805,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1078,1224843,1,1,,144209800,5280805,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1079,1224843,1,1,,170465691,5280805,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1080,1224844,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1081,1224844,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1082,1224845,1,1,,144209800,5280805,Inconclusive,344243002.0,100757539.0,32.1014,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1083,1224845,1,1,,170465691,5280805,Inconclusive,344243002.0,100757539.0,55.1965,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1084,1224846,1,1,,144209800,5280805,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1085,1224846,1,1,,170465691,5280805,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1086,1224847,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1087,1224847,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1088,1224848,3,1,,144209800,5280805,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1089,1224848,3,1,,170465691,5280805,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1090,1224849,3,1,,144209800,5280805,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1091,1224849,3,1,,170465691,5280805,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1092,1224857,2,1,,170465691,5280805,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1093,1224859,2,1,,170465691,5280805,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1094,1224867,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1095,1224867,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1096,1224868,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1097,1224868,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1098,1224869,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1099,1224869,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1100,1224870,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1101,1224870,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1102,1224871,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1103,1224871,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1104,1224872,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1105,1224872,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1106,1224873,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1107,1224873,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1108,1224874,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1109,1224874,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1110,1224875,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1111,1224875,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1112,1224876,1,1,,144209800,5280805,Inconclusive,,,15.6039,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1113,1224876,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1114,1224877,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1115,1224877,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1116,1224878,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1117,1224878,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1118,1224879,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1119,1224879,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1120,1224880,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1121,1224880,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1122,1224881,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1123,1224881,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1124,1224882,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1125,1224882,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1126,1224883,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1127,1224883,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1128,1224884,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1129,1224884,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1130,1224885,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1131,1224885,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1132,1224886,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1133,1224886,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1134,1224887,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1135,1224887,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1136,1224888,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1137,1224888,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1138,1224889,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1139,1224889,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1140,1224890,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1141,1224890,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1142,1224892,1,1,,144209800,5280805,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1143,1224892,1,1,,170465691,5280805,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1144,1224893,1,1,,144209800,5280805,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1145,1224893,1,1,,170465691,5280805,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1146,1224894,1,1,,144209800,5280805,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1147,1224894,1,1,,170465691,5280805,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1148,1224895,1,1,,144209800,5280805,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1149,1224895,1,1,,170465691,5280805,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1150,1224896,1,1,,144209800,5280805,Inconclusive,344243002.0,100757539.0,67.846,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1151,1224896,1,1,,170465691,5280805,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1152,1235282,1,1,,103516775,5280805,Inactive,,,,,Antimicrobial activity against Escherichia coli ATCC 25922 assessed as zone of inhibition at 1639 uM incubated overnight at 37 degC,Other,26151487.0,
1153,1235283,1,1,,103516775,5280805,Inactive,,,,,Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as zone of inhibition at 1639 uM incubated overnight at 37 degC,Other,26151487.0,
1154,1235284,1,1,,103516775,5280805,Inactive,,,,,Antimicrobial activity against methicillin-resistant Staphylococcus aureus 344/2-32 assessed as zone of inhibition at 1639 uM incubated overnight at 37 degC,Other,26151487.0,
1155,1235285,1,1,,103516775,5280805,Inactive,,,,,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as zone of inhibition at 1639 uM incubated overnight at 37 degC,Other,26151487.0,
1156,1235286,1,1,,103516775,5280805,Inactive,,,,,Antimicrobial activity against Streptococcus pyogenes 345/1 assessed as zone of inhibition at 1639 uM incubated overnight at 37 degC,Other,26151487.0,
1157,1235287,1,1,,103516775,5280805,Inactive,,,,,Antimicrobial activity against Candida albicans ATCC 10231 assessed as zone of inhibition at 1639 uM incubated overnight at 37 degC,Other,26151487.0,
1158,1243246,1,1,,103516775,5280805,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability at 10 to 40 uM by MTT assay,Other,26238320.0,
1159,1243247,1,1,,103516775,5280805,Inactive,,,,,Anti-inflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production at 10 uM by Griess reaction based ELISA method,Other,26238320.0,
1160,1243248,1,1,,103516775,5280805,Inactive,,,,,Anti-inflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production at 20 uM by Griess reaction based ELISA method,Other,26238320.0,
1161,1243249,1,1,,103516775,5280805,Inactive,,,,,Anti-inflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of nitric oxide production at 40 uM by Griess reaction based ELISA method,Other,26238320.0,
1162,1248399,1,1,,103516775,5280805,Unspecified,,,,IC50,Inhibition of alpha-amylase (unknown origin) relative to control,Confirmatory,26395057.0,
1163,1255828,1,1,,103516775,5280805,Unspecified,,,,,Neuroprotective activity against rotenone-induced cell damage in rat PC12 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay (Rvb = 53.9 +/- 7.1%),Other,26422318.0,
1164,1256761,1,1,,103516775,5280805,Inactive,,,,,Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate up to 50 nM by spectrophotometric analysis,Other,26491981.0,
1165,1256762,1,1,,103516775,5280805,Unspecified,,,,,Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate at 10 uM by spectrophotometric analysis relative to control,Other,26491981.0,
1166,1256763,1,1,,103516775,5280805,Unspecified,,,,IC50,Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate by spectrophotometric analysis,Confirmatory,26491981.0,
1167,1257224,1,1,,103516775,5280805,Active,,,10.2,IC50,Inhibition of Trichomonas vaginalis adenosine-guanosine preferring ribohydrolase after 40 mins,Confirmatory,26592812.0,
1168,1257225,1,1,,103516775,5280805,Active,,,17.3,IC50,Inhibition of Trichomonas vaginalis adenosine-guanosine preferring ribohydrolase after 40 mins in presence of 0.01% triton X-100,Confirmatory,26592812.0,
1169,1257226,1,1,,103516775,5280805,Inactive,,,,,Inhibition of Trichomonas vaginalis uridine ribohydrolase after 40 mins,Other,26592812.0,
1170,1259241,1,1,,144209800,5280805,Inconclusive,,,30.8561,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1171,1259241,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1172,1259242,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1173,1259242,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1174,1259243,1,1,,144209800,5280805,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1175,1259243,1,1,,170465691,5280805,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1176,1259244,1,1,,144209800,5280805,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1177,1259244,1,1,,170465691,5280805,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1178,1259247,1,1,,144209800,5280805,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1179,1259247,1,1,,170465691,5280805,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1180,1259248,1,1,,144209800,5280805,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1181,1259248,1,1,,170465691,5280805,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1182,1259251,1,1,,46386546,5280805,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of Unc-51 Like Autophagy Activating Kinase 1 (ULK1).,Screening,,
1183,1259310,1,1,,46386546,5280805,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1184,1259310,1,1,,333473023,5280805,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1185,1259325,1,2,,336955387,5280805,Inactive,4504843.0,3763.0,,,Discovering small molecule activators of G protein-gated inwardly-rectifying potassium subunit 2 (GIRK2) containing channels utilizing methyl-2 4-pentanediol (MPD) for partial channel activation during screening,Screening,,
1186,1259344,1,1,,144205498,5280805,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1187,1259355,1,1,,144205498,5280805,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
1188,1259356,1,1,,144205498,5280805,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
1189,1259364,1,1,,144209800,5280805,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1190,1259364,1,1,,170465691,5280805,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1191,1259365,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1192,1259365,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1193,1259366,1,1,,144209800,5280805,Inconclusive,,,38.8455,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1194,1259366,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1195,1259367,1,1,,144209800,5280805,Inconclusive,,,27.5005,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1196,1259367,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1197,1259368,1,1,,144209800,5280805,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1198,1259368,1,1,,170465691,5280805,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1199,1259369,1,1,,144209800,5280805,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1200,1259369,1,1,,170465691,5280805,Inactive,109731339.0,2737.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1201,1259377,1,1,,144209800,5280805,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1202,1259377,1,1,,170465691,5280805,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1203,1259378,1,1,,144209800,5280805,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1204,1259378,1,1,,170465691,5280805,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1205,1259379,1,1,,144209800,5280805,Inconclusive,,,69.0782,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1206,1259379,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1207,1259380,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1208,1259380,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1209,1259381,1,1,,144209800,5280805,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1210,1259381,1,1,,170465691,5280805,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1211,1259382,1,1,,144209800,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1212,1259382,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1213,1259383,1,1,,144209800,5280805,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1214,1259383,1,1,,170465691,5280805,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1215,1259384,1,1,,144209800,5280805,Inconclusive,,,54.8707,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1216,1259384,1,1,,170465691,5280805,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1217,1259385,1,1,,144209800,5280805,Inconclusive,119601739.0,7253.0,69.0782,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1218,1259385,1,1,,170465691,5280805,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1219,1259386,1,1,,144209800,5280805,Active,,,54.8707,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1220,1259386,1,1,,170465691,5280805,Inconclusive,,,23.7101,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1221,1259387,1,1,,144209800,5280805,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1222,1259387,1,1,,170465691,5280805,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1223,1259388,1,1,,144209800,5280805,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1224,1259388,1,1,,170465691,5280805,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1225,1259389,1,1,,124658987,5280805,Active,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1226,1259390,1,1,,144209800,5280805,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1227,1259390,1,1,,170465691,5280805,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1228,1259391,1,1,,144209800,5280805,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1229,1259391,1,1,,170465691,5280805,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1230,1259392,1,1,,144209800,5280805,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1231,1259392,1,1,,170465691,5280805,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1232,1259393,1,1,,144209800,5280805,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1233,1259393,1,1,,170465691,5280805,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1234,1259394,1,1,,144209800,5280805,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1235,1259394,1,1,,170465691,5280805,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1236,1259395,1,1,,144209800,5280805,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1237,1259395,1,1,,170465691,5280805,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1238,1259396,1,1,,144209800,5280805,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1239,1259396,1,1,,170465691,5280805,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1240,1259400,1,1,,170465691,5280805,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
1241,1259401,1,1,,144209800,5280805,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1242,1259401,1,1,,170465691,5280805,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1243,1259402,1,1,,144209800,5280805,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1244,1259402,1,1,,170465691,5280805,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1245,1259403,1,1,,144209800,5280805,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1246,1259403,1,1,,170465691,5280805,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1247,1259404,1,1,,144209800,5280805,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1248,1259404,1,1,,170465691,5280805,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1249,1259406,1,1,,363919898,5280805,Unspecified,,,,,BK Channel Variant Modulator Selectivity Assay,Screening,,
1250,1259406,1,1,1.0,363919898,5280805,Inactive,26638650.0,3778.0,-0.0318586,LogChange(F380Y),BK Channel Variant Modulator Selectivity Assay,Screening,,
1251,1259406,1,1,2.0,363919898,5280805,Inactive,4758626.0,3779.0,0.0399769,LogChange(F380Y/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
1252,1259406,1,1,3.0,363919898,5280805,Inactive,5031823.0,10242.0,0.0273129,LogChange(F380Y/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
1253,1259406,1,1,4.0,363919898,5280805,Inactive,26051275.0,27345.0,-0.024818700000000003,LogChange(F380Y/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
1254,1259406,1,1,5.0,363919898,5280805,Inactive,160410009.0,389816.0,-0.025997000000000003,LogChange(F380Y/Slo1WT/gamma1),BK Channel Variant Modulator Selectivity Assay,Screening,,
1255,1259406,1,1,6.0,363919898,5280805,Inactive,26638650.0,3778.0,0.0425755,LogChange(R275C),BK Channel Variant Modulator Selectivity Assay,Screening,,
1256,1259406,1,1,7.0,363919898,5280805,Inactive,4758626.0,3779.0,-0.00809686,LogChange(R275C/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
1257,1259406,1,1,8.0,363919898,5280805,Inactive,5031823.0,10242.0,0.00534785,LogChange(R275C/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
1258,1259406,1,1,9.0,363919898,5280805,Inactive,26051275.0,27345.0,-0.0011241,LogChange(R275C/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
1259,1259406,1,1,10.0,363919898,5280805,Inactive,5031823.0,10242.0,0.0255393,LogChange(R275C/Slo1WT/beta2),BK Channel Variant Modulator Selectivity Assay,Screening,,
1260,1259407,1,1,,363905514,5280805,Inactive,,,,,CCRIS mutagenicity studies,Other,,
1261,1259408,1,1,,363895505,5280805,Unspecified,,,,,GENE-TOX mutagenicity studies,Other,,
1262,1259409,1,1,,363905514,5280805,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
1263,1259413,1,2,,46386546,5280805,Inactive,47605623.0,173990.0,,,Modulators of fzo-1,Other,,
1264,1259416,1,2,,340082281,5280805,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1265,1259416,1,2,,375162936,5280805,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1266,1259421,1,1,,340082281,5280805,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1267,1259421,1,1,,375162936,5280805,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1268,1259423,1,2,,354913935,5280805,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
